Rank;Sourceid;Title;Type;Issn;SJR;SJR Best Quartile;H index;Total Docs. (2009);Total Docs. (3years);Total Refs.;Total Cites (3years);Citable Docs. (3years);Cites / Doc. (2years);Ref. / Doc.;Country;Region;Publisher;Coverage;Categories
1;19479;Annual Review of Pharmacology and Toxicology;journal;15454304, 03621642;11.689;Q1;210;19;64;2367;1512;64;24.47;124.58;United States;Northern America;Annual Reviews Inc.;1965-1973, 1975-2021;"Pharmacology (Q1); Toxicology (Q1)"
2;21191;Pharmacological Reviews;journal;15210081, 00316997;9.362;Q1;241;19;71;6531;1527;68;17.06;343.74;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1949, 1951-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
3;20425;Nature Reviews Drug Discovery;journal;14741784, 14741776;6.955;Q1;348;196;485;7293;5968;387;11.4;37.21;United Kingdom;Western Europe;Nature Publishing Group;2002-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
4;22321;Trends in Pharmacological Sciences;journal;18733735, 01656147;5.016;Q1;225;82;283;5642;2774;267;9.21;68.8;United Kingdom;Western Europe;Elsevier Ltd.;1979-2021;"Pharmacology (Q1); Toxicology (Q1)"
5;4700152457;Nano Today;journal;17480132;4.977;Q1;155;48;88;3092;614;53;7.5;64.42;Netherlands;Western Europe;Elsevier;1970, 2006-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
6;19409;Advanced Drug Delivery Reviews;journal;0169409X, 18728294;4.23;Q1;331;139;364;15218;4420;315;12.16;109.48;Netherlands;Western Europe;Elsevier;1987-2021;Pharmaceutical Science (Q1)
7;21195;Pharmacology and Therapeutics;journal;1879016X, 01637258;4.101;Q1;211;103;339;20152;3606;338;9.88;195.65;United States;Northern America;Elsevier Inc.;1975-1977, 1979-1985, 1987-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
8;13903;Cellular and Molecular Life Sciences;journal;1420682X, 14209071;3.995;Q1;233;299;845;28820;5651;841;6.44;96.39;Switzerland;Western Europe;Birkhauser Verlag Basel;1952, 1997-2021;"Cell Biology (Q1); Cellular and Molecular Neuroscience (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
9;12611;Drug Resistance Updates;journal;13687646, 15322084;3.991;Q1;119;16;52;1836;565;52;12.52;114.75;United States;Northern America;Churchill Livingstone;1998-2021;"Cancer Research (Q1); Infectious Diseases (Q1); Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
10;18017;Neuropsychopharmacology;journal;0893133X, 1470634X;3.59;Q1;227;255;836;16245;5588;801;6.84;63.71;United Kingdom;Western Europe;Nature Publishing Group;1987-2021;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
11;20681;Current Opinion in Pharmacology;journal;14714973, 14714892;3.52;Q1;139;116;305;6206;2192;274;7.04;53.5;Netherlands;Western Europe;Elsevier BV;2001-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
12;24032;Reviews of Physiology Biochemistry and Pharmacology;journal;16175786, 03034240;3.408;Q1;66;0;20;0;140;20;8.75;0;Germany;Western Europe;Springer Verlag;1974-2008, 2012-2018;"Biochemistry (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Physiology (Q1); Physiology (medical) (Q1)"
13;12455;Molecular Therapy;journal;15250024, 15250016;3.36;Q1;185;257;775;10612;4731;692;5.9;41.29;United States;Northern America;Cell Press;2000-2021;"Drug Discovery (Q1); Genetics (Q1); Medicine (miscellaneous) (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
14;19907;Medicinal Research Reviews;journal;01986325, 10981128;3.062;Q1;134;27;85;5423;821;85;9.41;200.85;United States;Northern America;"John Wiley &amp; Sons Inc.";1981-2021;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
15;26371;Natural Product Reports;journal;02650568, 14604752;2.925;Q1;188;77;186;11182;1453;181;7.69;145.22;United Kingdom;Western Europe;Royal Society of Chemistry;1984-2021;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
16;23010;Journal of Controlled Release;journal;18734995, 01683659;2.922;Q1;282;286;898;10748;5889;869;6.23;37.58;Netherlands;Western Europe;Elsevier;1984-2021;Pharmaceutical Science (Q1)
17;21100456838;Cell Chemical Biology;journal;24519448, 24519456;2.916;Q1;190;155;487;6139;2380;451;4.93;39.61;United States;Northern America;Elsevier Inc.;2016-2021;"Biochemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
18;18148;Pain;journal;18726623, 03043959;2.702;Q1;269;351;1036;13093;5992;819;5.41;37.3;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1975-2021;"Anesthesiology and Pain Medicine (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1)"
19;20626;Clinical Pharmacology and Therapeutics;journal;15326535, 00099236;2.51;Q1;195;241;678;5775;4008;570;5.49;23.96;United States;Northern America;Wiley-Blackwell;1960-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
20;19963;Molecular Pharmacology;journal;15210111, 0026895X;2.433;Q1;202;274;1166;12054;5712;1162;4.76;43.99;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1965-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
21;19615;Antimicrobial Agents and Chemotherapy;journal;10986596, 00664804;2.424;Q1;269;875;2216;27072;11992;2096;5.19;30.94;United States;Northern America;American Society for Microbiology;1963-1970, 1972-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
22;15984;Journal of Molecular Medicine;journal;09462716, 14321440;2.375;Q1;146;129;396;5819;1930;376;4.93;45.11;Germany;Western Europe;Springer Verlag;1976-1978, 1980-1981, 1995-2021;"Drug Discovery (Q1); Genetics (clinical) (Q1); Molecular Medicine (Q1)"
23;29311;Current Cancer Drug Targets;journal;15680096, 18735576;2.329;Q1;96;75;194;9712;1091;185;5.42;129.49;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Cancer Research (Q1); Drug Discovery (Q1); Pharmacology (Q1)"
24;5100155080;Neurotherapeutics;journal;19337213;2.326;Q1;122;75;198;6608;1180;183;6.31;88.11;United States;Northern America;Springer New York;2007-2021;"Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
25;20104;CNS Drug Reviews;journal;1080563X, 15273458;2.211;Q1;61;0;44;0;314;44;5.54;0;United States;Northern America;Neva Press, Inc.;1995-2007;"Neuropsychology and Physiological Psychology (Q1); Pharmacology (Q1)"
26;24749;Addiction Biology;journal;13556215, 13691600;2.185;Q1;83;54;116;3132;548;110;4.58;58;United States;Northern America;Wiley-Blackwell;1996-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
27;21782;Psychopharmacology;journal;00333158, 14322072;2.178;Q1;202;389;1063;23283;4790;1025;4.23;59.85;Germany;Western Europe;Springer Verlag;1959-2021;Pharmacology (Q1)
28;4400151524;Particle and Fibre Toxicology;journal;17438977;2.16;Q1;105;31;49;1670;330;46;5.18;53.87;United Kingdom;Western Europe;BioMed Central Ltd.;2004-2021;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
29;20084;British Journal of Pharmacology;journal;14765381, 00071188;2.126;Q1;223;610;1334;28479;7220;1288;5.48;46.69;United States;Northern America;Wiley-Blackwell;1965-2021;Pharmacology (Q1)
30;21000196010;Topics in antiviral medicine;journal;21615861, 21615853;2.076;Q1;43;18;63;311;300;62;6;17.28;United States;Northern America;International Antiviral Society;2011-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Virology (Q1)"
31;24661;Critical Reviews in Toxicology;journal;15476898, 10408444;2.075;Q1;117;38;105;5576;692;99;4.46;146.74;United Kingdom;Western Europe;Informa Healthcare;1971-2021;Toxicology (Q1)
32;16876;Bioconjugate Chemistry;journal;15204812, 10431802;2.037;Q1;177;286;817;12265;3876;814;4.55;42.88;United States;Northern America;American Chemical Society;1990-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
33;23041;Journal of Medicinal Chemistry;journal;00222623, 15204804;2.034;Q1;276;816;2454;34843;12921;2450;5.05;42.7;United States;Northern America;American Chemical Society;1959-1961, 1963-2021;"Drug Discovery (Q1); Molecular Medicine (Q1)"
34;26380;Drug and Alcohol Dependence;journal;03768716;2.025;Q1;173;263;725;12249;3002;700;3.97;46.57;Ireland;Western Europe;Elsevier Ireland Ltd;1975-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
35;25218;Toxicological Sciences;journal;10960929, 10966080;2.018;Q1;193;331;910;16093;4883;862;4.95;48.62;United Kingdom;Western Europe;Oxford University Press;1981-2021;Toxicology (Q1)
36;23916;Environmental Pollution;journal;02697491, 18736424;2.002;Q1;249;457;1429;20412;5864;1410;3.72;44.67;United Kingdom;Western Europe;Elsevier Ltd.;1970-1980, 1986-2022;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
37;22072;Current Gene Therapy;journal;18755631, 15665232;1.983;Q1;75;44;129;5188;715;126;5.81;117.91;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q1); Genetics (Q1); Genetics (clinical) (Q1); Molecular Medicine (Q1); Molecular Biology (Q2)"
38;21196;Drug Discovery Today;journal;18785832, 13596446;1.979;Q1;185;154;459;8116;2828;433;6.16;52.7;United Kingdom;Western Europe;Elsevier Ltd.;1996-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
39;22418;Journal of Antimicrobial Chemotherapy;journal;03057453, 14602091;1.902;Q1;203;583;1558;13684;6818;1238;4.27;23.47;United Kingdom;Western Europe;Oxford University Press;1975-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
40;22452;International Journal of Neuropsychopharmacology;journal;14611457, 14695111;1.897;Q1;113;136;294;6496;1149;263;4.07;47.76;United Kingdom;Western Europe;Oxford University Press;1998-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
41;20063;Biochemical Pharmacology;journal;18732968, 00062952;1.896;Q1;206;341;1070;18971;5316;994;4.5;55.63;United States;Northern America;Elsevier Inc.;1958-2021;"Biochemistry (Q1); Pharmacology (Q1)"
42;20129;Cardiovascular Drug Reviews;journal;15273466, 08975957;1.875;Q1;50;0;46;0;249;44;5.72;0;United States;Northern America;Neva Press, Inc.;1983-2007;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q1)"
43;23086;Journal of Pharmacology and Experimental Therapeutics;journal;15210103, 00223565;1.851;Q1;233;474;1670;17409;7532;1658;4.37;36.73;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1945-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
44;4400151701;Journal of Exposure Science and Environmental Epidemiology;journal;1559064X, 15590631;1.85;Q1;96;58;216;2371;631;200;2.73;40.88;United Kingdom;Western Europe;Nature Publishing Group;2006-2021;"Epidemiology (Q1); Pollution (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1)"
45;130126;Molecular Pharmaceutics;journal;15438384, 15438392;1.841;Q1;138;188;289;8631;1666;275;5.78;45.91;United States;Northern America;American Chemical Society;2004-2021;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmaceutical Science (Q1)"
46;18403;Apoptosis : an international journal on programmed cell death;journal;13608185, 1573675X;1.825;Q1;115;129;506;9689;2183;502;4.47;75.11;Netherlands;Western Europe;Springer Netherlands;1996-2021;"Biochemistry (medical) (Q1); Cancer Research (Q1); Clinical Biochemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Cell Biology (Q2)"
47;20435;Neuropharmacology;journal;00283908, 18737064;1.807;Q1;176;250;800;15008;3131;797;4.07;60.03;United Kingdom;Western Europe;Elsevier Ltd.;1962-2021;"Pharmacology (Q1); Cellular and Molecular Neuroscience (Q2)"
48;20664;Current Drug Targets;journal;18735592, 13894501;1.775;Q1;107;131;427;12582;1760;379;3.86;96.05;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2000-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
49;4500151409;CNS and Neurological Disorders - Drug Targets;journal;18715273;1.772;Q1;90;52;150;4787;613;134;3.83;92.06;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q1); Neuroscience (miscellaneous) (Q1); Pharmacology (Q1)"
50;23488;Current Medicinal Chemistry;journal;09298673, 1875533X;1.758;Q1;183;282;767;43990;4299;766;5.33;155.99;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1994-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
51;4000148203;Handbook of Experimental Pharmacology;journal;01712004;1.728;Q1;96;155;391;19347;1301;372;4.06;124.82;Germany;Western Europe;Springer Heidelberg;2004-2021;"Biochemistry (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
52;25152;Journal of Toxicology and Environmental Health - Part B: Critical Reviews;journal;10937404, 15216950;1.728;Q1;89;25;69;3489;349;64;4.2;139.56;United Kingdom;Western Europe;Taylor and Francis Ltd.;1998-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
53;20677;Current Opinion in Drug Discovery and Development;journal;13676733;1.722;Q1;81;73;215;5063;1027;197;5.07;69.36;United Kingdom;Western Europe;Current Drugs Ltd.;1998-2010;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
54;21168;Pharmacogenomics Journal;journal;1470269X, 14731150;1.676;Q1;90;48;146;2087;761;145;4.92;43.48;United Kingdom;Western Europe;Nature Publishing Group;2001-2021;"Molecular Medicine (Q1); Pharmacology (Q1); Genetics (Q2)"
55;11900154404;PLoS Neglected Tropical Diseases;journal;19352727, 19352735;1.637;Q1;143;225;220;9141;902;199;4.1;40.63;United States;Northern America;Public Library of Science;2007-2021;"Infectious Diseases (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Public Health, Environmental and Occupational Health (Q1)"
56;24791;Alcoholism: Clinical and Experimental Research;journal;01456008, 15300277;1.626;Q1;159;237;747;12669;2655;732;3.51;53.46;United States;Northern America;Wiley-Blackwell;1977-2021;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
57;21790;Antiviral Therapy;journal;20402058, 13596535;1.619;Q1;89;134;418;4995;1650;411;4.07;37.28;United Kingdom;Western Europe;International Medical Press Ltd;1996-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
58;4000149101;Nanomedicine: Nanotechnology, Biology, and Medicine;journal;15499634, 15499642;1.612;Q1;133;60;114;2107;638;111;6.13;35.12;United States;Northern America;Elsevier Inc.;2005-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2)"
59;4700152872;Journal of NeuroImmune Pharmacology;journal;15571890, 15571904;1.608;Q1;77;47;119;3276;515;114;2.97;69.7;United States;Northern America;Springer New York;2006-2021;"Immunology and Allergy (Q1); Pharmacology (Q1); Immunology (Q2); Neuroscience (miscellaneous) (Q2)"
60;20682;Current Pharmaceutical Design;journal;13816128, 18734286;1.605;Q1;166;349;1097;40829;4808;980;4.54;116.99;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1995-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
61;130044;Pharmacogenetics and Genomics;journal;17446880, 17446872;1.593;-;144;116;332;4363;1598;327;4.5;37.61;United States;Northern America;Lippincott Williams and Wilkins Ltd.;2005-2021;"Genetics (Q2); Genetics (clinical) (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
62;21123;Pharmaceutical Research;journal;07248741, 1573904X;1.585;Q1;213;258;810;12028;3683;787;4.4;46.62;United States;Northern America;Springer New York;1984-2021;"Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Molecular Medicine (Q2)"
63;110112;Journal of Immunotherapy;journal;15249557, 15374513;1.583;Q1;97;99;247;3955;963;245;3.66;39.95;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1991-2021;"Immunology and Allergy (Q1); Pharmacology (Q1); Cancer Research (Q2); Immunology (Q2)"
64;26512;Tetrahedron;journal;14645416, 00404020;1.545;Q1;226;1290;3974;66897;13262;3941;3.46;51.86;United Kingdom;Western Europe;Elsevier Ltd.;1957-2021;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
65;12331;Current Topics in Medicinal Chemistry;journal;15680266, 18734294;1.542;Q1;122;143;505;12891;2033;435;3.89;90.15;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1)"
66;21332;European Journal of Pharmaceutics and Biopharmaceutics;journal;18733441, 09396411;1.533;Q1;168;195;650;8882;2520;645;3.73;45.55;Netherlands;Western Europe;Elsevier;1991-2021;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)"
67;24649;Chemical Research in Toxicology;journal;15205010, 0893228X;1.506;Q1;163;227;705;10511;2842;682;3.98;46.3;United States;Northern America;American Chemical Society;1988-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
68;20624;Clinical Pharmacokinetics;journal;11791926, 03125963;1.494;Q1;169;60;212;4237;1142;202;5.34;70.62;United Kingdom;Western Europe;Adis International Ltd;1976-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
69;16088;Journal of Nanobiotechnology;journal;14773155;1.49;Q1;84;10;39;361;178;37;5.48;36.1;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2021;"Applied Microbiology and Biotechnology (Q1); Bioengineering (Q1); Biomedical Engineering (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2); Nanoscience and Nanotechnology (Q2)"
70;20659;Critical Reviews in Therapeutic Drug Carrier Systems;journal;07434863, 2162660X;1.487;Q1;76;12;39;2263;178;39;4.31;188.58;United States;Northern America;Begell House Inc.;1984-2021;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
71;5400152706;Nanotoxicology;journal;17435390, 17435404;1.478;Q1;94;34;51;1379;287;50;5.63;40.56;United Kingdom;Western Europe;Informa Healthcare;2007-2021;"Biomedical Engineering (Q1); Toxicology (Q1); Nanoscience and Nanotechnology (Q2)"
72;21226;Drug Metabolism and Disposition;journal;00909556, 1521009X;1.472;Q1;182;300;901;9694;3873;895;4.09;32.31;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1973-2021;"Pharmaceutical Science (Q1); Pharmacology (Q1)"
73;21354;Expert Opinion on Therapeutic Targets;journal;14728222, 17447631;1.469;Q1;94;116;345;11796;1223;321;3.82;101.69;United Kingdom;Western Europe;Taylor and Francis Ltd.;1997-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
74;23053;Journal of Natural Products;journal;01633864, 15206025;1.466;Q1;147;421;1228;11749;4065;1222;3.37;27.91;United States;Northern America;American Chemical Society;1949, 1971, 1973, 1978-2021;"Analytical Chemistry (Q1); Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
75;144771;Clinical Trials;journal;17407753, 17407745;1.453;Q1;67;64;170;1742;316;150;1.7;27.22;United Kingdom;Western Europe;SAGE Publications Ltd;2004-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
76;12584;Drug Metabolism Reviews;journal;10979883, 03602532;1.45;Q1;100;26;113;4882;568;108;4.97;187.77;United States;Northern America;Informa Healthcare;1972-2021;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
77;4000148019;AAPS Journal;journal;15507416;1.441;Q1;118;81;198;4702;1047;195;4.08;58.05;United States;Northern America;Springer New York;1999-2021;Pharmaceutical Science (Q1)
78;29318;Anti-Cancer Agents in Medicinal Chemistry;journal;18715206, 18755992;1.424;Q1;100;93;182;9648;833;167;4.33;103.74;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Pharmacology (Q1); Cancer Research (Q2); Molecular Medicine (Q2)"
79;24763;Addictive Behaviors;journal;03064603;1.407;Q1;135;177;714;6804;2006;713;2.67;38.44;United Kingdom;Western Europe;Elsevier Ltd.;1975-2022;"Clinical Psychology (Q1); Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
80;22454;International Journal of Pharmaceutics;journal;18733476, 03785173;1.399;Q1;229;525;1714;17057;6390;1700;3.52;32.49;Netherlands;Western Europe;Elsevier;1978-2021;Pharmaceutical Science (Q1)
81;20049;Behavioural Pharmacology;journal;14735849, 09558810;1.393;Q1;83;82;243;4585;737;240;2.97;55.91;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1992-2021;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
82;21237;Drug Safety;journal;01145916, 11791942;1.384;Q1;131;99;305;5046;1231;257;3.82;50.97;United Kingdom;Western Europe;Adis International Ltd;1990-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1)"
83;25075;Ecotoxicology;journal;09639292, 15733017;1.38;Q1;97;133;212;5298;712;211;3.84;39.83;Netherlands;Western Europe;Springer Netherlands;1992-2021;"Health, Toxicology and Mutagenesis (Q1); Management, Monitoring, Policy and Law (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
84;23109;Journal of Psychopharmacology;journal;14617285, 02698811;1.378;Q1;121;128;394;5266;1262;343;2.8;41.14;United Kingdom;Western Europe;SAGE Publications Ltd;1987-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
85;14144;Experimental and Clinical Psychopharmacology;journal;19362293, 10641297;1.367;Q1;95;49;165;2355;487;165;2.98;48.06;United States;Northern America;American Psychological Association;1993-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
86;7000153203;Journal of Studies on Alcohol and Drugs;journal;19371888, 19384114;1.339;Q1;129;112;330;4787;941;325;2.17;42.74;United States;Northern America;Alcohol Research Documentation, Inc.;2007-2021;"Health (social science) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
87;21169;Pharmacological Research;journal;10436618, 10961186;1.333;Q1;147;125;386;7568;1497;375;4.41;60.54;United States;Northern America;Academic Press Inc.;1989-2021;Pharmacology (Q1)
88;15576;European Neuropsychopharmacology;journal;0924977X, 18737862;1.309;Q1;118;110;313;5066;1110;306;3.52;46.05;Netherlands;Western Europe;Elsevier;1990-2021;"Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Biological Psychiatry (Q2); Neurology (Q2)"
89;21197;Pharmacology Biochemistry and Behavior;journal;00913057, 18735177;1.309;Q1;139;265;688;14111;2106;684;3.14;53.25;United States;Northern America;Elsevier Inc.;1973-2021;"Clinical Biochemistry (Q1); Pharmacology (Q1); Toxicology (Q1); Behavioral Neuroscience (Q2); Biochemistry (Q2); Biological Psychiatry (Q2)"
90;25109;Inhalation Toxicology;journal;08958378, 10917691;1.302;Q1;90;152;373;5787;1167;355;3.46;38.07;United Kingdom;Western Europe;Informa Healthcare;1989-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
91;26514;Tetrahedron Letters;journal;00404039, 18733581;1.296;Q1;173;1866;5706;62623;16402;5705;2.92;33.56;United Kingdom;Western Europe;Elsevier Ltd.;1959-2021;"Drug Discovery (Q1); Organic Chemistry (Q1); Biochemistry (Q2)"
92;21767;Progress in Neuro-Psychopharmacology and Biological Psychiatry;journal;18784216, 02785846;1.291;Q1;134;288;846;12937;2396;721;2.76;44.92;United States;Northern America;Elsevier Inc.;1982-2022;"Pharmacology (Q1); Biological Psychiatry (Q2)"
93;25222;Toxicology and Applied Pharmacology;journal;10960333, 0041008X;1.29;Q1;175;320;933;16671;3518;917;3.75;52.1;United States;Northern America;Academic Press Inc.;1959-2021;"Pharmacology (Q1); Toxicology (Q1)"
94;21124;Pharmaceutical Statistics;journal;15391612, 15391604;1.283;Q1;39;32;90;745;134;79;1.61;23.28;United Kingdom;Western Europe;John Wiley and Sons Ltd;2004-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Statistics and Probability (Q2)"
95;28792;Cancer Biology and Therapy;journal;15384047, 15558576;1.28;Q1;120;371;994;13406;2366;760;2.27;36.13;United States;Northern America;Landes Bioscience;2002-2021;"Oncology (Q1); Pharmacology (Q1); Cancer Research (Q2); Molecular Medicine (Q2)"
96;20783;Expert Review of Vaccines;journal;14760584, 17448395;1.278;Q1;91;156;310;11295;1137;276;3.96;72.4;United Kingdom;Western Europe;Taylor and Francis Ltd.;2002-2021;"Drug Discovery (Q1); Pharmacology (Q1); Immunology (Q2); Molecular Medicine (Q2)"
97;19617;Antiviral Research;journal;01663542, 18729096;1.277;Q1;134;132;369;6144;1556;367;4.12;46.55;Netherlands;Western Europe;Elsevier;1959, 1981-2021;"Pharmacology (Q1); Virology (Q2)"
98;20679;Current Opinion in Investigational Drugs;journal;20403429, 14724472;1.276;Q1;79;136;371;9871;1300;339;3.63;72.58;United Kingdom;Western Europe;Current Drugs Ltd.;2000-2010;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
99;18922;Journal of Gene Medicine;journal;1099498X, 15212254;1.26;Q1;94;112;357;3924;1198;356;3.27;35.04;United States;Northern America;John Wiley and Sons Ltd;1998-2021;"Drug Discovery (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
100;23079;Journal of Pharmaceutical Sciences;journal;15206017, 00223549;1.253;Q1;186;391;926;17420;3171;871;3.37;44.55;United States;Northern America;"John Wiley &amp; Sons Inc.";1961-2021;Pharmaceutical Science (Q1)
101;21351;Expert Opinion on Investigational Drugs;journal;13543784, 17447658;1.251;Q1;109;165;481;12080;1948;449;4.52;73.21;United Kingdom;Western Europe;Taylor and Francis Ltd.;1994-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
102;20680;Current Opinion in Molecular Therapeutics;journal;14648431;1.249;Q1;66;77;212;5421;731;194;3.73;70.4;United Kingdom;Western Europe;Current Drugs Ltd.;1999-2010;"Drug Discovery (Q1); Pharmacology (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
103;15581;Current Pharmaceutical Biotechnology;journal;13892010, 18734316;1.249;Q1;88;85;170;5699;605;150;3.88;67.05;Netherlands;Western Europe;Bentham Science Publishers B.V.;2000-2021;"Biotechnology (Q1); Pharmaceutical Science (Q1)"
104;23014;Journal of Drug Targeting;journal;10292330, 1061186X;1.236;Q1;95;85;240;3038;790;229;3.23;35.74;United Kingdom;Western Europe;Informa Healthcare;1986-1987, 1992-2021;Pharmaceutical Science (Q1)
105;22983;Journal of Clinical Pharmacology;journal;15524604, 00912700;1.235;Q1;121;142;454;4013;1674;432;3.84;28.26;United States;Northern America;Wiley-Blackwell;1973-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
106;20663;Current Drug Metabolism;journal;18755453, 13892002;1.223;Q1;111;90;255;12668;1269;245;4.42;140.76;Netherlands;Western Europe;Bentham Science Publishers B.V.;2000-2021;"Clinical Biochemistry (Q1); Pharmacology (Q1)"
107;110172;Progress in Drug Research;book series;0071786X;1.223;Q1;44;0;33;0;109;30;3.3;0;Switzerland;Western Europe;Birkhauser Verlag Basel;1959-1966, 1968-1969, 1972-2003, 2005, 2007-2008, 2011, 2014-2018;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Molecular Medicine (Q2)"
108;4400151608;ChemMedChem;journal;18607187, 18607179;1.205;Q1;106;218;530;9458;1770;522;3.34;43.39;United Kingdom;Western Europe;John Wiley and Sons Ltd;2006-2021;"Organic Chemistry (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Molecular Medicine (Q2)"
109;23061;Journal of Pharmaceutical and Biomedical Analysis;journal;07317085, 1873264X;1.2;Q1;133;359;1557;9245;4518;1548;2.84;25.75;Netherlands;Western Europe;Elsevier;1983-2022;"Analytical Chemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmaceutical Science (Q1); Spectroscopy (Q1)"
110;19427;Advances in Pharmacology;journal;15578925, 10543589;1.198;Q1;78;14;73;1944;220;68;3.81;138.86;United States;Northern America;Academic Press Inc.;1962-1964, 1966-1973, 1975, 1977-1982, 1984, 1990-2000, 2004-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
111;22552;Cardiovascular Drugs and Therapy;journal;15737241, 09203206;1.194;Q1;71;70;184;2583;435;149;2.24;36.9;Netherlands;Western Europe;Kluwer Academic Publishers;1987-2021;"Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
112;20082;British Journal of Clinical Pharmacology;journal;13652125, 03065251;1.187;Q1;153;216;725;6383;2293;558;3;29.55;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1974-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
113;18073;NeuroToxicology;journal;18729711, 0161813X;1.187;Q1;122;166;442;7899;1487;414;3.07;47.58;Netherlands;Western Europe;Elsevier;1979-2021;"Toxicology (Q1); Neuroscience (miscellaneous) (Q2)"
114;21165;PharmacoEconomics;journal;11707690, 11792027;1.186;Q1;104;91;305;3631;815;244;2.62;39.9;United Kingdom;Western Europe;Adis International Ltd;1992-2021;"Health Policy (Q1); Pharmacology (Q1); Public Health, Environmental and Occupational Health (Q1)"
115;21331;European Journal of Pharmaceutical Sciences;journal;18790720, 09280987;1.18;Q1;144;189;398;7302;1540;390;2.85;38.63;Netherlands;Western Europe;Elsevier;1993-2021;Pharmaceutical Science (Q1)
116;4600151527;Infectious Disorders - Drug Targets;journal;18715265;1.17;Q1;55;53;96;5332;290;86;2.78;100.6;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q1); Microbiology (medical) (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
117;18966;Mutagenesis;journal;02678357, 14643804;1.169;Q1;95;62;173;2947;697;167;3.76;47.53;United Kingdom;Western Europe;Oxford University Press;1986-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1); Genetics (Q2); Genetics (clinical) (Q2)"
118;25219;Toxicology;journal;0300483X, 18793185;1.159;Q1;165;252;887;10760;3190;869;3.46;42.7;Ireland;Western Europe;Elsevier Ireland Ltd;1959, 1973-2021;Toxicology (Q1)
119;18075;Neurotoxicology and Teratology;journal;08920362, 18729738;1.15;Q1;103;48;180;2778;581;178;3.25;57.88;United States;Northern America;Elsevier Inc.;1987-2021;"Toxicology (Q1); Developmental Neuroscience (Q2); Cellular and Molecular Neuroscience (Q3)"
120;22477;Investigational New Drugs;journal;01676997, 15730646;1.146;Q1;90;73;202;2268;600;201;3.2;31.07;Netherlands;Western Europe;Kluwer Academic Publishers;1983-2021;"Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
121;20427;Naunyn-Schmiedeberg's Archives of Pharmacology;journal;00281298, 14321912;1.142;Q1;93;119;303;4882;887;296;2.94;41.03;Germany;Western Europe;Springer Verlag;1969-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
122;13250;Expert Opinion on Biological Therapy;journal;14712598, 17447682;1.137;Q1;91;141;454;11591;1558;448;3.56;82.21;United Kingdom;Western Europe;Taylor and Francis Ltd.;2001-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1)"
123;84948;Expert Opinion on Drug Delivery;journal;17425247;1.136;Q1;116;100;218;9913;755;204;3.18;99.13;United Kingdom;Western Europe;Taylor and Francis Ltd.;2004-2021;Pharmaceutical Science (Q1)
124;24603;Archives of Environmental Contamination and Toxicology;journal;14320703, 00904341;1.135;Q1;115;172;459;7030;1023;459;1.91;40.87;United States;Northern America;Springer New York;1973-2021;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
125;25786;Bioorganic and Medicinal Chemistry;journal;14643391, 09680896;1.13;Q1;171;887;2541;33854;8200;2538;3.03;38.17;United Kingdom;Western Europe;Elsevier Ltd.;1993-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Biochemistry (Q2); Molecular Medicine (Q2); Molecular Biology (Q3)"
126;20051;BioDrugs;journal;11738804, 1179190X;1.124;Q1;71;35;126;2782;440;117;4.21;79.49;United Kingdom;Western Europe;Adis International Ltd;1997-2021;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
127;25788;Bioorganic and Medicinal Chemistry Letters;journal;14643405, 0960894X;1.123;Q1;154;1487;3860;39170;11076;3859;2.88;26.34;United Kingdom;Western Europe;Elsevier Ltd.;1991-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Biochemistry (Q2); Molecular Medicine (Q2); Molecular Biology (Q3)"
128;25240;Toxicology Letters;journal;03784274, 18793169;1.09;Q1;150;295;628;11836;2378;607;3.63;40.12;Netherlands;Western Europe;Elsevier BV;1977-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
129;29097;Cancer Chemotherapy and Pharmacology;journal;14320843, 03445704;1.088;Q1;114;293;683;9069;1952;673;2.86;30.95;Germany;Western Europe;Springer Verlag;1978-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1); Cancer Research (Q2); Oncology (Q2)"
130;24619;Journal of Computer-Aided Molecular Design;journal;15734951, 0920654X;1.085;Q1;104;78;193;3338;717;186;3.68;42.79;Netherlands;Western Europe;Springer Netherlands;1987-2021;"Computer Science Applications (Q1); Drug Discovery (Q1); Physical and Theoretical Chemistry (Q2)"
131;23015;Journal of Ethnopharmacology;journal;03788741, 18727573;1.085;Q1;205;481;1304;17466;4281;1290;2.89;36.31;Ireland;Western Europe;Elsevier Ireland Ltd;1979-2022;"Drug Discovery (Q1); Pharmacology (Q1)"
132;23085;Journal of Pharmacological Sciences;journal;13478648, 13478613;1.081;Q2;87;200;557;6931;1533;551;2.38;34.66;Japan;Asiatic Region;Japanese Pharmacological Society;1996-2021;"Molecular Medicine (Q2); Pharmacology (Q2)"
133;29712;Clinical Therapeutics;journal;1879114X, 01492918;1.079;Q2;140;287;764;9619;2795;695;3.37;33.52;United States;Northern America;Elsevier Inc.;1977-2021;"Pharmacology (medical) (Q1); Pharmacology (Q2)"
134;23081;Journal of Pharmacokinetics and Pharmacodynamics;journal;15738744, 1567567X;1.077;Q2;64;32;103;869;239;101;2.25;27.16;United States;Northern America;Springer New York;1996-1999, 2001-2021;Pharmacology (Q2)
135;25125;Journal of Analytical Toxicology;journal;19452403, 01464760;1.07;Q1;78;103;339;2161;751;314;2.31;20.98;United States;Northern America;Preston Publications;1977-2021;"Chemical Health and Safety (Q1); Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1); Analytical Chemistry (Q2); Environmental Chemistry (Q2)"
136;17595;Journal of Biomolecular Screening;journal;10870571, 1552454X;1.067;Q1;79;117;306;2914;796;304;2.48;24.91;United States;Northern America;SAGE Publications Inc.;1996-2017;"Biotechnology (Q1); Drug Discovery (Q1); Analytical Chemistry (Q2); Biochemistry (Q2); Molecular Medicine (Q2); Pharmacology (Q2)"
137;22981;Journal of Cardiovascular Pharmacology;journal;15334023, 01602446;1.063;Q2;104;146;510;6660;1539;496;3.12;45.62;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1979-2021;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q2)"
138;21167;Pharmacogenomics;journal;14622416, 17448042;1.051;Q2;94;184;468;8961;1608;412;3.34;48.7;United Kingdom;Western Europe;Future Medicine Ltd.;2000-2021;"Genetics (Q2); Molecular Medicine (Q2); Pharmacology (Q2)"
139;18071;Neurotoxicity Research;journal;14763524, 10298428;1.05;Q2;78;79;155;4576;503;155;2.78;57.92;United States;Northern America;Springer New York;1999, 2001-2021;"Neuroscience (miscellaneous) (Q2); Toxicology (Q2)"
140;22378;Vascular Pharmacology;journal;18793649, 15371891;1.049;Q2;100;79;272;3287;741;266;2.18;41.61;United States;Northern America;Elsevier Inc.;2002-2021;"Molecular Medicine (Q2); Pharmacology (Q2); Physiology (Q2)"
141;21333;European Journal of Pharmacology;journal;00142999, 18790712;1.048;Q2;189;602;2382;26573;7260;2376;2.92;44.14;Netherlands;Western Europe;Elsevier;1967-2021;Pharmacology (Q2)
142;110174;Prostaglandins and Other Lipid Mediators;journal;10988823;1.047;Q2;76;58;165;2772;425;163;2.71;47.79;United States;Northern America;Elsevier Inc.;1996, 1998-2021;"Biochemistry (Q2); Pharmacology (Q2); Physiology (Q2); Cell Biology (Q3)"
143;23155;Current Vascular Pharmacology;journal;15701611, 18756212;1.046;Q2;63;56;109;6582;351;102;3.11;117.54;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2003-2021;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q2)"
144;19900193739;Nucleic Acid Therapeutics;journal;21593345, 21593337;1.042;Q1;70;34;109;1415;283;107;2.72;41.62;United States;Northern America;Mary Ann Liebert Inc.;2011-2021;"Drug Discovery (Q1); Biochemistry (Q2); Genetics (Q2); Molecular Medicine (Q2); Molecular Biology (Q3)"
145;16948;Chirality;journal;1520636X, 08990042;1.04;Q1;80;150;347;6302;869;342;2.7;42.01;United States;Northern America;Wiley-Liss Inc.;1989-2021;"Drug Discovery (Q1); Analytical Chemistry (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Spectroscopy (Q2); Catalysis (Q3)"
146;21100370879;"Journal of managed care &amp; specialty pharmacy";journal;23761032, 23760540;1.039;Q1;66;88;337;2922;676;228;2.05;33.2;United States;Northern America;Academy of Managed Care Pharmacy (AMCP);2014-2021;"Health Policy (Q1); Pharmaceutical Science (Q1); Pharmacy (Q1)"
147;14990;Current Neuropharmacology;journal;18756190, 1570159X;1.038;Q2;82;35;81;3841;198;79;2.09;109.74;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;"Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Neurology (Q2); Neurology (clinical) (Q2); Pharmacology (Q2)"
148;20473;Life Sciences;journal;18790631, 00243205;1.029;Q1;174;252;1483;10044;4512;1482;2.91;39.86;United States;Northern America;Elsevier Inc.;1962-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
149;7700153108;International Journal of Nanomedicine;journal;11782013, 11769114;1.018;Q2;145;33;158;727;514;151;3.1;22.03;New Zealand;Pacific Region;Dove Medical Press Ltd.;2006-2021;"Medicine (miscellaneous) (Q1); Bioengineering (Q2); Biomaterials (Q2); Biophysics (Q2); Drug Discovery (Q2); Nanoscience and Nanotechnology (Q2); Organic Chemistry (Q2)"
150;24652;Chemico-Biological Interactions;journal;00092797;1.001;Q2;128;291;504;12860;1698;497;2.68;44.19;Ireland;Western Europe;Elsevier Ireland Ltd;1969-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
151;9000153111;Comparative Biochemistry and Physiology Part - C: Toxicology and Pharmacology;journal;15320456, 18781659;0.99;Q2;113;162;396;8150;1134;394;2.78;50.31;United States;Northern America;Elsevier Inc.;1989, 2000-2022;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Biochemistry (Q2); Physiology (Q2); Toxicology (Q2); Cell Biology (Q3)"
152;5800173387;Reviews on Recent Clinical Trials;journal;15748871;0.987;Q2;32;26;85;1496;253;80;3.13;57.54;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
153;28636;Birth Defects Research Part B - Developmental and Reproductive Toxicology;journal;15429733, 15429741;0.984;Q2;52;40;111;1541;264;101;2.3;38.53;United States;Northern America;Wiley-Liss Inc.;2003-2016;"Embryology (Q2); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Developmental Biology (Q3)"
154;24797;Mini-Reviews in Medicinal Chemistry;journal;18755607, 13895575;0.984;Q2;95;149;394;14757;1309;391;3.26;99.04;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2)"
155;144956;Drug Metabolism and Pharmacokinetics;journal;13474367;0.981;Q1;69;72;185;2621;573;175;2.69;36.4;Japan;Asiatic Region;Japanese Society for the Study of Xenobiotics;2002-2021;"Pharmaceutical Science (Q1); Pharmacology (medical) (Q1); Pharmacology (Q2)"
156;4000150314;Chemical Biology and Drug Design;journal;17470277;0.964;-;82;148;336;5435;901;325;2.52;36.72;United Kingdom;Western Europe;Blackwell;2006-2021;"Biochemistry (Q2); Molecular Medicine (Q2)"
157;17464;European Journal of Medicinal Chemistry;journal;02235234, 17683254;0.964;Q2;175;624;656;22026;2304;656;3.44;35.3;France;Western Europe;Elsevier Masson s.r.l.;1974-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2)"
158;24786;Alcohol and Alcoholism;journal;07350414, 14643502;0.958;Q2;103;113;325;4634;878;307;2.44;41.01;United Kingdom;Western Europe;Oxford University Press;1965-2021;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q2)"
159;5800173385;Recent Patents on Anti-Cancer Drug Discovery;journal;15748928;0.954;Q2;46;27;72;2740;245;72;3.04;101.48;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1); Cancer Research (Q2); Drug Discovery (Q2); Oncology (Q2)"
160;4700152848;PPAR Research;journal;16874757, 16874765;0.952;Q2;52;39;169;2968;391;158;2.34;76.1;United States;Northern America;Hindawi Publishing Corporation;2006-2021;"Pharmacology (medical) (Q1); Drug Discovery (Q2)"
161;4700152856;Expert Opinion on Drug Metabolism and Toxicology;journal;17425255;0.951;Q2;88;125;259;11138;972;253;3.56;89.1;United Kingdom;Western Europe;Taylor and Francis Ltd.;2005-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Toxicology (Q2)"
162;21841;Food Additives and Contaminants;journal;0265203X, 14645122;0.945;Q2;102;0;319;0;920;315;2.69;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1984-2008;"Chemistry (miscellaneous) (Q1); Food Science (Q1); Public Health, Environmental and Occupational Health (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
163;28727;Anti-Cancer Drugs;journal;09594973, 14735741;0.941;Q2;96;132;434;4194;1186;431;2.62;31.77;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1990-2021;"Pharmacology (medical) (Q1); Cancer Research (Q2); Oncology (Q2); Pharmacology (Q2)"
164;24785;Alcohol;journal;07418329;0.94;Q2;83;69;195;3689;474;190;2.58;53.46;United States;Northern America;Elsevier Inc.;1984-2021;"Health (social science) (Q1); Medicine (miscellaneous) (Q1); Biochemistry (Q2); Neurology (Q2); Toxicology (Q2); Behavioral Neuroscience (Q3)"
165;24028;Reproductive Toxicology;journal;08906238, 18731708;0.937;Q2;117;118;385;5617;1333;357;3.8;47.6;United States;Northern America;Elsevier Inc.;1987-2021;Toxicology (Q2)
166;11900154314;Cardiovascular Therapeutics;journal;17555914, 17555922;0.927;Q2;48;37;32;1698;95;28;2.97;45.89;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2008-2021;"Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1); Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2)"
167;19034;Microbial Drug Resistance;journal;10766294, 19318448;0.915;Q2;72;51;134;1183;293;134;2.08;23.2;United States;Northern America;Mary Ann Liebert Inc.;1995-2021;"Medicine (miscellaneous) (Q1); Microbiology (Q2); Microbiology (medical) (Q2); Pharmacology (Q2); Immunology (Q3)"
168;4100151708;Inflammation and Allergy - Drug Targets;journal;18715281;0.911;Q2;51;51;97;3969;286;92;3.02;77.82;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2015;"Medicine (miscellaneous) (Q1); Immunology and Allergy (Q2); Pharmacology (Q2); Immunology (Q3)"
169;14805;Steroids;journal;0039128X, 18785867;0.907;Q2;107;144;424;5192;1206;420;3.19;36.06;United States;Northern America;Elsevier Inc.;1963-2021;"Biochemistry (Q2); Clinical Biochemistry (Q2); Endocrinology (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Biology (Q3)"
170;24604;Archives of Toxicology;journal;14320738, 03405761;0.892;Q2;121;127;309;5526;988;295;3.34;43.51;Germany;Western Europe;Springer Verlag;1930-1940, 1943-1944, 1972-2021;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
171;17067;Phytomedicine;journal;09447113, 1618095X;0.89;Q1;127;158;427;4522;1269;414;2.81;28.62;Germany;Western Europe;Urban und Fischer Verlag Jena;1994-2021;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q1); Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
172;13845;Bulletin of Mathematical Biology;journal;00928240, 15229602;0.884;Q2;90;87;324;3457;652;321;2.06;39.74;United States;Northern America;Springer New York;1973-2021;"Agricultural and Biological Sciences (miscellaneous) (Q1); Environmental Science (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Computational Theory and Mathematics (Q2); Mathematics (miscellaneous) (Q2); Neuroscience (miscellaneous) (Q2); Pharmacology (Q2); Immunology (Q3)"
173;22575;Cardiovascular Toxicology;journal;15307905, 15590259;0.884;Q2;56;27;76;1104;226;76;2.86;40.89;United States;Northern America;Humana Press;2001-2021;"Cardiology and Cardiovascular Medicine (Q2); Toxicology (Q2); Molecular Biology (Q3)"
174;23382;Clinical and Experimental Pharmacology and Physiology;journal;14401681, 03051870;0.873;Q2;107;199;712;8256;1716;691;2.1;41.49;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1974-2021;"Pharmacology (Q2); Physiology (Q2); Physiology (medical) (Q2)"
175;14822;Xenobiotica;journal;00498254, 13665928;0.865;Q2;82;100;252;3638;743;249;3.07;36.38;United Kingdom;Western Europe;Informa Healthcare;1971-2021;"Medicine (miscellaneous) (Q1); Biochemistry (Q2); Health, Toxicology and Mutagenesis (Q2); Pharmacology (Q2); Toxicology (Q2)"
176;21350;Expert Opinion on Emerging Drugs;journal;14728214, 17447623;0.863;Q2;51;45;134;5224;384;134;3;116.09;United Kingdom;Western Europe;Taylor and Francis Ltd.;2000-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
177;19984;Assay and Drug Development Technologies;journal;1540658X, 15578127;0.859;Q2;58;43;286;1203;410;162;1.3;27.98;United States;Northern America;Mary Ann Liebert Inc.;2002-2021;"Drug Discovery (Q2); Molecular Medicine (Q3)"
178;22299;Therapeutic Drug Monitoring;journal;15363694, 01634356;0.858;Q2;96;99;384;3775;1019;360;2.65;38.13;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1979-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
179;20602;Clinical Neuropharmacology;journal;1537162X, 03625664;0.856;Q2;80;97;179;2350;503;165;2.79;24.23;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1982-2021;"Neurology (clinical) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
180;34645;Skin Pharmacology and Physiology;journal;16605527, 16605535;0.851;Q2;78;43;128;1543;371;115;2.49;35.88;Switzerland;Western Europe;S. Karger AG;1988-1997, 2004-2021;"Dermatology (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q2); Physiology (Q2)"
181;22982;Journal of Cardiovascular Pharmacology and Therapeutics;journal;10742484, 19404034;0.848;Q2;52;38;98;1324;218;94;2.27;34.84;United Kingdom;Western Europe;SAGE Publications Ltd;1996-2021;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
182;21326;European Journal of Clinical Pharmacology;journal;00316970, 14321041;0.845;Q2;114;171;508;5278;1419;452;2.77;30.87;Germany;Western Europe;Springer Verlag;1968-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
183;11700154735;Journal of Aerosol Medicine and Pulmonary Drug Delivery;journal;19412703, 19412711;0.841;Q1;73;31;156;902;304;136;1.56;29.1;United States;Northern America;Mary Ann Liebert Inc.;2008-2021;"Pharmaceutical Science (Q1); Pharmacology (medical) (Q2); Pulmonary and Respiratory Medicine (Q2)"
184;28620;Biomedicine and Pharmacotherapy;journal;07533322;0.839;Q2;109;115;326;3677;929;317;2.56;31.97;France;Western Europe;Elsevier Masson s.r.l.;1982-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
185;11700154316;CNS Neuroscience and Therapeutics;journal;17555949, 17555930;0.839;Q2;75;35;31;2080;85;30;2.74;59.43;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2008-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2); Physiology (medical) (Q2); Psychiatry and Mental Health (Q2)"
186;25096;Food and Chemical Toxicology;journal;18736351, 02786915;0.833;Q2;183;416;1217;16972;3280;1197;2.47;40.8;United Kingdom;Western Europe;Elsevier Ltd.;1982-2021;"Food Science (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q2)"
187;25151;Journal of Toxicology and Environmental Health - Part A: Current Issues;journal;10872620, 15287394;0.833;Q2;92;184;558;7154;1074;545;1.84;38.88;United Kingdom;Western Europe;Taylor and Francis Ltd.;1996-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
188;19900192900;Molecular Informatics;journal;18681751, 18681743;0.83;Q2;70;124;289;4213;835;278;3.05;33.98;Germany;Western Europe;"Wiley - VCH Verlag GmbH &amp; CO. KGaA";2010-2021;"Computer Science Applications (Q1); Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Medicine (Q3); Structural Biology (Q3)"
189;25214;Toxicologic Pathology;journal;15331601, 01926233;0.83;Q2;112;105;337;4313;775;321;2.16;41.08;United States;Northern America;SAGE Publications Inc.;1972-2021;"Pathology and Forensic Medicine (Q2); Toxicology (Q2); Cell Biology (Q3); Molecular Biology (Q3)"
190;22318;Toxicological Reviews;journal;11762551;0.823;Q2;46;0;20;0;103;20;0;0;United Kingdom;Western Europe;Adis International Ltd;2003-2006;"Pharmacology (Q2); Toxicology (Q2)"
191;23942;Biomedical Chromatography;journal;10990801, 02693879;0.822;Q2;68;175;544;4467;1041;538;1.88;25.53;United Kingdom;Western Europe;John Wiley and Sons Ltd;1986-2021;"Medicine (miscellaneous) (Q1); Analytical Chemistry (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Biology (Q3)"
192;130025;Current Drug Delivery;journal;15672018;0.808;Q1;65;64;126;2687;355;125;2.78;41.98;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;Pharmaceutical Science (Q1)
193;5800173383;Current Clinical Pharmacology;journal;15748847, 22123938;0.796;Q1;0;0;0;0;0;0;0;0;United Arab Emirates;Middle East;Bentham Science Publishers;2006-2020;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2)"
194;25789;Bioorganic Chemistry;journal;00452068, 10902120;0.792;Q2;66;31;114;1207;223;112;1.69;38.94;United States;Northern America;Academic Press Inc.;1971-2021;"Drug Discovery (Q2); Organic Chemistry (Q2); Biochemistry (Q3); Molecular Biology (Q3)"
195;22432;International Immunopharmacology;journal;18781705, 15675769;0.791;Q2;119;234;696;9398;1756;680;2.45;40.16;Netherlands;Western Europe;Elsevier;2001-2021;"Immunology and Allergy (Q2); Pharmacology (Q2); Immunology (Q3)"
196;25224;Toxicology in Vitro;journal;18793177, 08872333;0.791;Q2;112;215;629;8422;1717;620;2.4;39.17;United Kingdom;Western Europe;Elsevier Ltd.;1987-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
197;21744;Planta Medica;journal;14390221, 00320943;0.777;Q1;122;244;742;6120;1627;735;2.01;25.08;Germany;Western Europe;Georg Thieme Verlag;1961, 1965-2021;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
198;25146;Journal of Pharmacological and Toxicological Methods;journal;10568719;0.771;Q2;75;57;193;1887;462;186;2.38;33.11;United States;Northern America;Elsevier Inc.;1992-2002, 2004-2021;"Pharmacology (Q2); Toxicology (Q2)"
199;130063;Pharmacological Reports;journal;17341140;0.77;Q2;87;132;364;6082;863;363;2.26;46.08;Netherlands;Western Europe;Elsevier BV;2005-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
200;20047;Basic and Clinical Pharmacology and Toxicology;journal;17427843, 17427835;0.758;Q2;93;134;465;4864;1196;458;2.46;36.3;United States;Northern America;Wiley-Blackwell;2004-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Toxicology (Q2)"
201;22319;Toxicon;journal;18793150, 00410101;0.756;Q2;133;246;733;10875;1763;720;2.32;44.21;United Kingdom;Western Europe;Elsevier Ltd.;1962-2021;Toxicology (Q2)
202;18500157900;Food Additives and Contaminants - Part A Chemistry, Analysis, Control, Exposure and Risk Assessment;journal;19440057, 19440049;0.754;Q2;80;181;173;5342;415;170;2.4;29.51;United Kingdom;Western Europe;Taylor and Francis Ltd.;2008-2021;"Chemistry (miscellaneous) (Q1); Food Science (Q1); Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q2)"
203;4200151509;Molecular Diagnosis and Therapy;journal;11771062;0.754;Q2;47;34;123;2398;310;117;2.49;70.53;United Kingdom;Western Europe;Adis International Ltd;2001, 2004, 2006-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Genetics (Q3); Molecular Medicine (Q3)"
204;4400151410;Human Vaccines;journal;15548600, 15548619;0.751;Q1;58;150;175;5531;373;147;1.98;36.87;United States;Northern America;Landes Bioscience;2005-2011;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Immunology (Q3)"
205;23039;Journal of Liposome Research;journal;08982104, 15322394;0.751;Q1;53;38;84;1518;196;84;2;39.95;United Kingdom;Western Europe;Informa Healthcare;1988-1990, 1992-2021;Pharmaceutical Science (Q1)
206;23363;Canadian Journal of Physiology and Pharmacology;journal;00084212, 12057541;0.749;Q2;87;126;401;6161;747;394;1.51;48.9;Canada;Northern America;National Research Council of Canada;1964-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (medical) (Q2); Physiology (Q3)"
207;21455;Progress in Medicinal Chemistry;journal;00796468, 18757863;0.746;Q2;36;14;21;961;36;17;1.92;68.64;Netherlands;Western Europe;Elsevier;1961-1963, 1965, 1967, 1969-2021;"Pharmacology (Q2); Molecular Medicine (Q3)"
208;20634;Journal of Texture Studies;journal;00224901, 17454603;0.744;Q1;57;43;124;1177;204;120;1.44;27.37;United States;Northern America;Wiley-Blackwell;1969-2021;"Food Science (Q1); Pharmaceutical Science (Q1)"
209;5800173402;Recent Patents on CNS Drug Discovery;journal;15748898;0.743;Q2;34;19;70;2426;195;70;2.89;127.68;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2016;"Drug Discovery (Q2); Pharmacology (medical) (Q2); Psychiatry and Mental Health (Q2)"
210;14487;Journal of Ocular Pharmacology and Therapeutics;journal;15577732, 10807683;0.741;Q2;64;86;218;2478;407;213;1.84;28.81;United States;Northern America;Mary Ann Liebert Inc.;1987, 1991-1993, 1995-2021;"Ophthalmology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
211;25176;Regulatory Toxicology and Pharmacology;journal;02732300, 10960295;0.739;Q2;112;125;343;4877;778;311;1.95;39.02;United States;Northern America;Academic Press Inc.;1970, 1981-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q2)"
212;20064;Biological and Pharmaceutical Bulletin;journal;13475215, 09186158;0.737;Q1;122;383;1406;11850;3107;1403;2.09;30.94;Japan;Asiatic Region;Pharmaceutical Society of Japan;1993-2021;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
213;145164;Human Genomics;journal;14739542, 14797364;0.735;Q2;59;43;43;720;64;32;1.2;16.74;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2006, 2008-2021;"Drug Discovery (Q2); Genetics (Q3); Molecular Biology (Q3); Molecular Medicine (Q3)"
214;4600151526;Cardiovascular and Hematological Disorders - Drug Targets;journal;1871529X;0.724;Q2;42;31;89;2650;209;88;2.28;85.48;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Cardiology and Cardiovascular Medicine (Q2); Hematology (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
215;16533;Phytochemical Analysis;journal;09580344, 10991565;0.723;Q2;76;68;206;1568;357;205;1.79;23.06;United Kingdom;Western Europe;John Wiley and Sons Ltd;1990-2021;"Complementary and Alternative Medicine (Q1); Food Science (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Plant Science (Q2); Biochemistry (Q3); Molecular Medicine (Q3)"
216;22769;Chemical and Pharmaceutical Bulletin;journal;00092363, 13475223;0.719;Q2;95;282;1075;6881;2016;1075;1.84;24.4;Japan;Asiatic Region;Pharmaceutical Society of Japan;1958-2021;"Chemistry (miscellaneous) (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2)"
217;21865;Fundamental and Clinical Pharmacology;journal;07673981, 14728206;0.707;Q2;77;90;228;3924;545;222;2.37;43.6;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1987-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
218;23412;Journal of AOAC International;journal;10603271;0.696;Q2;90;248;613;5339;1005;606;1.39;21.53;United States;Northern America;AOAC International;1993-2021;"Agronomy and Crop Science (Q1); Food Science (Q1); Analytical Chemistry (Q2); Environmental Chemistry (Q2); Pharmacology (Q2)"
219;16573;Phytotherapy Research;journal;10991573, 0951418X;0.696;Q2;140;300;719;9084;1716;717;2.16;30.28;United Kingdom;Western Europe;John Wiley and Sons Ltd;1987-2021;Pharmacology (Q2)
220;29550;Journal of Biochemical and Molecular Toxicology;journal;10956670, 10990461;0.692;Q2;62;46;144;1724;299;138;2.08;37.48;United States;Northern America;"John Wiley &amp; Sons Inc.";1998-2021;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2); Biochemistry (Q3); Molecular Biology (Q3); Molecular Medicine (Q3)"
221;25093;Environmental Toxicology;journal;15227278, 15204081;0.69;Q2;81;70;246;3067;484;244;1.87;43.81;United States;Northern America;"John Wiley &amp; Sons Inc.";1980, 1999-2021;"Health, Toxicology and Mutagenesis (Q2); Management, Monitoring, Policy and Law (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2)"
222;20570;Chemotherapy;journal;00093157, 14219794;0.681;Q2;58;59;207;1858;390;202;2.07;31.49;Switzerland;Western Europe;S. Karger AG;1960-2021;"Drug Discovery (Q2); Infectious Diseases (Q2); Medicine (miscellaneous) (Q2); Oncology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
223;24074;Helvetica Chimica Acta;journal;0018019X, 15222675;0.676;Q2;85;265;748;7702;1212;748;1.63;29.06;United States;Northern America;Wiley-Blackwell;1918-2021;"Drug Discovery (Q2); Inorganic Chemistry (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Biochemistry (Q3); Catalysis (Q3)"
224;19443;American Journal of Health-System Pharmacy;journal;10792082, 15352900;0.672;Q2;99;384;1302;6317;1761;868;1.35;16.45;United States;Northern America;American Society of Health-Systems Pharmacy;1995-2021;"Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
225;15840;Journal of Antibiotics;journal;00218820, 18811469;0.671;Q2;84;119;300;2715;492;300;1.63;22.82;United Kingdom;Western Europe;Japan Antibiotics Research Association;1953-2021;"Drug Discovery (Q2); Pharmacology (Q2)"
226;4700152612;Current Nanoscience;journal;15734137;0.664;Q1;47;73;125;3658;246;122;1.62;50.11;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Pharmaceutical Science (Q1); Bioengineering (Q2); Biomedical Engineering (Q2); Biotechnology (Q2); Medicine (miscellaneous) (Q2); Nanoscience and Nanotechnology (Q3)"
227;23050;Journal of Microencapsulation;journal;02652048, 14645246;0.662;Q1;81;81;196;2502;369;195;1.66;30.89;United Kingdom;Western Europe;Informa Healthcare;1984-2021;"Pharmaceutical Science (Q1); Bioengineering (Q2); Colloid and Surface Chemistry (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2)"
228;22410;Inflammation Research;journal;1420908X, 10233830;0.66;Q2;94;156;366;5026;633;362;1.68;32.22;Switzerland;Western Europe;Birkhauser Verlag Basel;1995-2021;"Pharmacology (Q2); Immunology (Q3)"
229;25898;Journal of Peptide Science;journal;10752617, 10991387;0.659;Q2;68;112;374;4419;633;364;1.78;39.46;United Kingdom;Western Europe;John Wiley and Sons Ltd;1995-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Biology (Q3); Molecular Medicine (Q3); Structural Biology (Q3)"
230;23129;Journal of Veterinary Pharmacology and Therapeutics;journal;01407783, 13652885;0.648;Q2;62;211;268;3346;438;262;1.43;15.86;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1978-2021;"Veterinary (miscellaneous) (Q1); Pharmacology (Q2)"
231;19374;AAPS PharmSciTech;journal;15309932;0.646;Q1;101;175;386;5215;741;381;1.47;29.8;Switzerland;Western Europe;Springer International Publishing AG;2000-2021;"Agronomy and Crop Science (Q1); Pharmaceutical Science (Q1); Aquatic Science (Q2); Drug Discovery (Q2); Ecology (Q2); Ecology, Evolution, Behavior and Systematics (Q2); Medicine (miscellaneous) (Q2)"
232;23035;Journal of Biopharmaceutical Statistics;journal;10543406, 15205711;0.642;Q2;52;80;233;1455;241;208;1.05;18.19;United States;Northern America;Taylor and Francis Ltd.;1991-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2); Statistics and Probability (Q3)"
233;16836;BMC Chemical Biology;journal;14726769;0.634;Q2;20;7;8;330;14;8;1.8;47.14;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Drug Discovery (Q2); Molecular Medicine (Q3)"
234;23479;Journal of Physiology and Pharmacology;journal;08675910, 18991505;0.633;Q2;81;206;635;6419;1135;622;1.61;31.16;Poland;Eastern Europe;Polish Physiological Society;1991-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (Q3)"
235;21194;Pharmacology;journal;00317012, 14230313;0.631;Q2;60;112;231;4257;445;228;2;38.01;Switzerland;Western Europe;S. Karger AG;1959-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
236;4400151415;Cardiovascular and Hematological Agents in Medicinal Chemistry;journal;18715257;0.628;Q2;40;30;99;3163;208;98;2.11;105.43;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Cardiology and Cardiovascular Medicine (Q2); Hematology (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
237;5800228222;Journal of Pharmaceutical Innovation;journal;18725120, 19398042;0.628;Q2;31;24;56;368;61;47;1;15.33;United States;Northern America;Springer New York;2006-2021;"Drug Discovery (Q2); Pharmaceutical Science (Q2)"
238;20580;Journal of Food Biochemistry;journal;17454514, 01458884;0.627;Q2;50;59;153;1953;189;153;0.95;33.1;United States;Northern America;Wiley-Blackwell;1977-2021;"Biophysics (Q2); Food Science (Q2); Pharmacology (Q2); Cell Biology (Q3)"
239;19403;Acta Pharmacologica Sinica;journal;16714083, 17457254;0.624;Q2;98;199;659;8200;1232;657;1.81;41.21;United Kingdom;Western Europe;Nature Publishing Group;1980-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
240;23007;Journal of Clinical Pharmacy and Therapeutics;journal;13652710, 02694727;0.622;Q2;76;90;264;2551;576;242;2.02;28.34;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1976-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
241;20027;BMC Pharmacology;journal;14712210;0.62;Q2;44;19;53;530;95;53;1.38;27.89;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
242;20770;Drug Delivery;journal;10717544, 15210464;0.62;Q2;72;60;181;1724;339;180;1.63;28.73;United Kingdom;Western Europe;Informa Healthcare;1993, 1995-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
243;21229;Drug News and Perspectives;journal;02140934;0.62;Q2;51;70;225;3821;349;222;1.56;54.59;Spain;Western Europe;Prous Science;1990-2010;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
244;24578;Mathematical Medicine and Biology;journal;14778599;0.62;Q2;46;26;62;1023;106;61;1.28;39.35;United Kingdom;Western Europe;Oxford University Press;1984-2021;"Applied Mathematics (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Environmental Science (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Modeling and Simulation (Q2); Pharmacology (Q2); Immunology and Microbiology (miscellaneous)  (Q3); Neuroscience (miscellaneous) (Q3)"
245;23453;Combinatorial Chemistry and High Throughput Screening;journal;13862073, 18755402;0.619;Q2;66;101;256;5737;600;236;2.55;56.8;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1998-2021;"Computer Science Applications (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2)"
246;23102;Journal of Pharmacy and Pharmacology;journal;20427158, 00223573;0.618;Q2;124;208;616;8460;1281;608;1.98;40.67;United Kingdom;Western Europe;Oxford University Press;1949-2021;"Pharmaceutical Science (Q2); Pharmacology (Q2)"
247;6400153120;Chinese Medicine;journal;17498546;0.617;Q2;45;24;34;1143;91;32;2.4;47.63;United Kingdom;Western Europe;BioMed Central Ltd.;2006-2021;"Complementary and Alternative Medicine (Q1); Pharmacology (Q2)"
248;21352;Expert Opinion on Pharmacotherapy;journal;17447666, 14656566;0.613;Q2;83;271;794;20462;1903;773;2.51;75.51;United Kingdom;Western Europe;Taylor and Francis Ltd.;1999-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
249;25106;Human and Experimental Toxicology;journal;09603271;0.612;Q2;82;106;338;2567;659;309;1.57;24.22;United States;Northern America;SAGE Publications Inc.;1981-2021;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2)"
250;29953;Journal of Experimental Therapeutics and Oncology;journal;13594117, 1533869X;0.61;Q2;38;16;78;712;134;77;1.53;44.5;United States;Northern America;Old City Publishing;1996, 2002-2020;"Drug Discovery (Q2); Pharmacology (Q2); Cancer Research (Q3)"
251;16067;Reading Teacher;journal;00340561;0.61;Q2;53;80;243;1594;179;241;0.6;19.93;United States;Northern America;Wiley-Blackwell;1995-2021;"Linguistics and Language (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
252;4000148406;Clinical Toxicology;journal;15569519, 15563650;0.605;Q2;98;145;432;3811;660;358;1.44;26.28;United Kingdom;Western Europe;Informa Healthcare;1968-1998, 2005-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q2)"
253;11500153306;Recent Patents on Drug Delivery and Formulation;journal;22124039, 18722113;0.601;Q2;36;19;44;2089;81;44;1.84;109.95;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2020;"Biomedical Engineering (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
254;20026;BMC Clinical Pharmacology;journal;14726904;0.599;Q2;39;19;34;679;82;34;2.42;35.74;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
255;25095;Environmental Toxicology and Pharmacology;journal;13826689;0.597;Q2;88;133;319;5521;494;316;1.55;41.51;Netherlands;Western Europe;Elsevier;1996-2021;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2)"
256;29053;Molecular Diversity;journal;1573501X, 13811991;0.597;Q2;58;48;97;3137;295;94;2.02;65.35;Netherlands;Western Europe;Springer Netherlands;1995-1998, 2000, 2003-2021;"Drug Discovery (Q2); Information Systems (Q2); Inorganic Chemistry (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Catalysis (Q3); Physical and Theoretical Chemistry (Q3); Molecular Biology (Q4)"
257;25864;Heterocycles;journal;03855414;0.591;Q2;66;397;1137;12455;1430;1129;1.33;31.37;Japan;Asiatic Region;Japan Institute of Heterocyclic Chemistry;1983-2021;"Analytical Chemistry (Q2); Organic Chemistry (Q2); Pharmacology (Q2)"
258;5900153312;Recent Patents on Cardiovascular Drug Discovery;journal;15748901;0.589;Q2;28;28;78;2051;174;78;2.29;73.25;Netherlands;Western Europe;Bentham Science Publishers B.V.;2006-2015;"Cardiology and Cardiovascular Medicine (Q2); Drug Discovery (Q2); Pharmacology (medical) (Q2)"
259;19700185200;Journal of Natural Medicines;journal;13403443, 18610293;0.583;Q2;50;82;244;1643;284;242;1.24;20.04;Germany;Western Europe;Springer Verlag;2006-2021;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Organic Chemistry (Q3)"
260;27087;American Journal of Therapeutics;journal;10752765, 15363686;0.579;Q2;63;104;294;3290;510;270;1.7;31.63;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1960-1961, 1996-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
261;18077;Fitoterapia;journal;0367326X, 18736971;0.579;Q2;110;104;414;2686;765;414;1.62;25.83;Netherlands;Western Europe;Elsevier;1948-1949, 1961, 1972-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
262;25126;Journal of Applied Toxicology;journal;10991263, 0260437X;0.579;Q3;91;90;265;4146;609;260;2.32;46.07;United Kingdom;Western Europe;John Wiley and Sons Ltd;1981-2021;Toxicology (Q3)
263;19956;Archiv der Pharmazie;journal;15214184, 03656233;0.578;Q2;65;74;240;2204;425;237;1.94;29.78;Germany;Western Europe;Wiley-VCH Verlag;1822-1831, 1835-1933, 1937-1938, 1940, 1943-1944, 1950-2021;"Drug Discovery (Q2); Pharmaceutical Science (Q2)"
264;11700154733;Journal of Biomedical Nanotechnology;journal;15507041, 15507033;0.577;Q2;80;88;107;3733;177;102;1.65;42.42;United States;Northern America;American Scientific Publishers;2007-2020;"Biomedical Engineering (Q2); Materials Science (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Bioengineering (Q3); Nanoscience and Nanotechnology (Q3)"
265;21256;Drugs of Today;journal;00257656, 16993993, 16994019;0.569;Q2;53;102;266;6046;529;261;2;59.27;Spain;Western Europe;Prous Science;1968, 1978-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
266;15462;Biotechnology and Applied Biochemistry;journal;14708744, 08854513;0.564;Q2;74;88;205;3622;425;204;2.01;41.16;United States;Northern America;Wiley-Blackwell;1986-2021;"Applied Microbiology and Biotechnology (Q2); Biomedical Engineering (Q2); Biotechnology (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Process Chemistry and Technology (Q2); Bioengineering (Q3); Molecular Medicine (Q3)"
267;21099;Pharmaceutical Development and Technology;journal;10837450, 10979867;0.563;Q2;62;78;179;2255;229;176;1.07;28.91;United States;Northern America;Informa Healthcare;1996-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
268;21264;Drugs in R and D;journal;11796901, 11745886;0.56;Q2;47;0;121;0;282;120;2.42;0;United Kingdom;Western Europe;Adis International Ltd;1999, 2002-2008, 2010-2021;Pharmacology (Q2)
269;16319;IEEE Transactions on Nanobioscience;journal;15361241, 15582639;0.56;Q2;65;42;119;1366;275;115;2.17;32.52;United States;Northern America;Institute of Electrical and Electronics Engineers Inc.;2002-2021;"Biomedical Engineering (Q2); Biotechnology (Q2); Computer Science Applications (Q2); Electrical and Electronic Engineering (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Bioengineering (Q3); Nanoscience and Nanotechnology (Q3)"
270;24626;Cell Biology and Toxicology;journal;15736822, 07422091;0.555;Q3;64;49;140;2512;288;140;2.16;51.27;Netherlands;Western Europe;Springer Netherlands;1984-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q3); Cell Biology (Q4)"
271;19700182275;International Journal of Clinical Pharmacy;journal;22107711, 22107703;0.554;Q2;63;74;240;1717;333;226;1.27;23.2;Netherlands;Western Europe;Springer Netherlands;2011-2021;"Pharmacy (Q1); Pharmaceutical Science (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Toxicology (Q3)"
272;130047;Current Drug Discovery Technologies;journal;15701638;0.553;Q2;44;27;88;2842;161;86;1.92;105.26;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;Drug Discovery (Q2)
273;24640;Journal of Liquid Chromatography and Related Technologies;journal;1520572X, 10826076;0.548;Q2;51;210;644;5104;706;638;1.09;24.3;United States;Northern America;Taylor and Francis Ltd.;1996-2021;"Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Biochemistry (Q3); Clinical Biochemistry (Q3)"
274;29845;IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer;book series;10171606;0.546;Q3;48;0;32;0;76;31;2.18;0;France;Western Europe;International Agency for Research on Cancer;1988-1997, 1999-2002, 2004, 2006-2008, 2010-2020;"Cancer Research (Q3); Toxicology (Q3)"
275;25149;Journal of Toxicological Sciences;journal;18803989, 03881350;0.542;Q3;53;123;180;3197;340;175;1.84;25.99;Japan;Asiatic Region;Japanese Society of Toxicological Sciences;1976-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
276;22434;International Journal of Clinical Pharmacology and Therapeutics;journal;09461965;0.533;Q3;69;131;268;2903;433;245;1.61;22.16;Germany;Western Europe;Dustri-Verlag Dr. Karl Feistle;1994-2021;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
277;16803;Antiviral Chemistry and Chemotherapy;journal;20402066, 09563202;0.53;Q2;54;17;79;891;153;77;2.1;52.41;United Kingdom;Western Europe;SAGE Publications Inc.;1991-2015, 2017-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3); Virology (Q3)"
278;26370;Molecules;journal;14203049;0.528;Q2;171;406;573;15748;1102;563;1.96;38.79;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);1992, 1996-2021;"Chemistry (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Molecular Medicine (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3)"
279;23089;Journal of Pharmacy and Pharmaceutical Sciences;journal;14821826;0.525;Q2;81;33;143;1498;314;143;2.02;45.39;Canada;Northern America;Canadian Society for Pharmaceutical Sciences;1998-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q3)"
280;12000154522;Advances in Antiviral Drug Design;book series;10758593;0.523;Q1;12;0;7;0;14;6;2;0;United Kingdom;Western Europe;Elsevier Ltd.;1996, 1999, 2003, 2007;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2); Infectious Diseases (Q3); Virology (Q3)"
281;25305;SAR and QSAR in Environmental Research;journal;1029046X, 1062936X;0.523;Q3;50;38;131;1604;246;128;1.7;42.21;United Kingdom;Western Europe;Taylor and Francis Ltd.;1993-2021;"Medicine (miscellaneous) (Q2); Bioengineering (Q3); Drug Discovery (Q3); Molecular Medicine (Q3)"
282;19700174918;Clinical and Translational Science;journal;17528062, 17528054;0.52;Q1;48;128;61;3232;46;48;0.75;25.25;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2008-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Neuroscience (miscellaneous) (Q3)"
283;28794;Cancer Biotherapy and Radiopharmaceuticals;journal;10849785, 15578852;0.512;Q3;63;88;246;3003;363;237;1.55;34.13;United States;Northern America;Mary Ann Liebert Inc.;1996-2021;"Medicine (miscellaneous) (Q2); Oncology (Q2); Radiology, Nuclear Medicine and Imaging (Q2); Cancer Research (Q3); Pharmacology (Q3)"
284;26767;Altex;journal;1868596X, 18688551;0.509;Q3;57;27;132;1043;134;122;1.14;38.63;Germany;Western Europe;Springer International Publishing AG;2000-2021;"Medical Laboratory Technology (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
285;21190;Drug Development and Industrial Pharmacy;journal;03639045, 15205762;0.505;Q3;90;167;422;5151;539;418;1.24;30.84;United States;Northern America;Informa Healthcare;1974, 1976-2021;"Drug Discovery (Q3); Organic Chemistry (Q3); Pharmacology (Q3)"
286;25129;Journal of Environmental Pathology, Toxicology and Oncology;journal;07318898;0.5;Q3;47;34;105;1287;218;105;1.51;37.85;United States;Northern America;Begell House Inc.;1984-1990, 1992-2021;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
287;4900153304;Archives of Environmental and Occupational Health;journal;19338244;0.496;Q3;64;44;103;1645;111;86;1.17;37.39;United States;Northern America;Heldref Publications;2005-2021;"Environmental Science (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
288;21100241807;Artificial Cells, Nanomedicine and Biotechnology;journal;2169141X, 21691401;0.488;Q2;57;42;145;915;160;144;0.79;21.79;United States;Northern America;Informa Healthcare;2013-2021;"Biotechnology (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Biomedical Engineering (Q3)"
289;22411;Inflammopharmacology;journal;09254692, 15685608;0.478;Q3;55;32;131;2045;221;127;1.78;63.91;Switzerland;Western Europe;Birkhauser Verlag Basel;1991-2021;"Pharmacology (medical) (Q2); Immunology (Q3); Pharmacology (Q3)"
290;21353;Expert Opinion on Therapeutic Patents;journal;13543776, 17447674;0.477;Q3;77;109;332;9508;405;321;1.21;87.23;United Kingdom;Western Europe;Taylor and Francis Ltd.;1991-2021;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
291;24624;Bulletin of Environmental Contamination and Toxicology;journal;00074861, 14320800;0.476;Q3;76;328;750;5712;746;749;1.1;17.41;United States;Northern America;Springer New York;1966-2021;"Medicine (miscellaneous) (Q2); Pollution (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
292;4700152903;Forensic Toxicology;journal;18608965, 18608973;0.47;Q3;39;21;55;374;52;52;1.03;17.81;Japan;Asiatic Region;Springer Japan;2006-2021;"Biochemistry (medical) (Q2); Pathology and Forensic Medicine (Q2); Toxicology (Q3)"
293;6800153101;Expert Opinion on Drug Discovery;journal;1746045X, 17460441;0.463;Q3;68;92;303;9533;411;296;1.42;103.62;United Kingdom;Western Europe;Informa Healthcare;2006-2021;Drug Discovery (Q3)
294;25111;International Journal of Toxicology;journal;10915818, 1092874X;0.462;Q3;62;53;194;2522;311;192;1.37;47.58;United States;Northern America;SAGE Publications Inc.;1982-2021;Toxicology (Q3)
295;17605;Journal of Enzyme Inhibition and Medicinal Chemistry;journal;14756374, 14756366;0.461;Q3;79;178;333;5426;539;330;1.54;30.48;United Kingdom;Western Europe;Informa Healthcare;1985-2021;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
296;13248;Experimental and Toxicologic Pathology;journal;09402993, 16181433;0.458;Q3;70;58;211;2087;350;204;1.51;35.98;Germany;Western Europe;Urban und Fischer Verlag Jena;1992-2017;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q3); Toxicology (Q3); Cell Biology (Q4)"
297;5800173403;Recent Patents on Anti-Infective Drug Discovery;journal;1574891X, 22124071;0.457;Q3;0;0;0;0;0;0;0;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2006-2020;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Drug Discovery (Q3); Infectious Diseases (Q3)"
298;19700177407;Interdisciplinary Toxicology;journal;13379569, 13376853;0.456;Q3;34;26;26;872;30;26;1.15;33.54;Slovakia;Eastern Europe;Slovak Toxicology Society SETOX;2008-2020;"Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
299;4700152603;Medicinal Chemistry;journal;15734064, 18756638;0.453;Q3;46;71;218;2381;393;218;1.7;33.54;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2005-2021;Drug Discovery (Q3)
300;19441;American Journal of Drug Delivery;journal;11759038;0.452;Q3;22;0;28;0;39;24;0;0;United Kingdom;Western Europe;Adis International Ltd;2004-2006;Pharmacology (Q3)
301;19600166302;Current Molecular Pharmacology;journal;18744702;0.438;Q3;42;27;23;3594;29;23;1.26;133.11;United Arab Emirates;Middle East;Bentham Science Publishers;2008-2021;"Drug Discovery (Q3); Molecular Medicine (Q3); Pharmacology (Q3)"
302;144790;Marine Drugs;journal;16603397;0.437;Q3;128;52;69;2923;180;69;2.88;56.21;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2003-2021;Drug Discovery (Q3)
303;21192;Drug Development Research;journal;02724391, 10982299;0.434;Q3;62;54;216;3111;286;204;0.7;57.61;United States;Northern America;"John Wiley &amp; Sons Inc.";1981-2021;Drug Discovery (Q3)
304;4700152609;Current Computer-Aided Drug Design;journal;15734099;0.428;Q3;31;21;82;2108;135;76;1.78;100.38;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Molecular Medicine (Q3)"
305;26568;International Journal of Cosmetic Science;journal;01425463, 14682494;0.428;Q2;66;39;136;1194;217;130;1.38;30.62;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1979-2021;"Chemistry (miscellaneous) (Q2); Dermatology (Q2); Pharmaceutical Science (Q2); Aging (Q3); Colloid and Surface Chemistry (Q3); Drug Discovery (Q3)"
306;13671;Biologicals;journal;10958320, 10451056;0.426;Q3;60;72;159;1336;225;144;1.38;18.56;United States;Northern America;Academic Press Inc.;1990-2021;"Medicine (miscellaneous) (Q2); Applied Microbiology and Biotechnology (Q3); Bioengineering (Q3); Biotechnology (Q3); Immunology and Microbiology (miscellaneous)  (Q3); Pharmacology (Q3)"
307;28675;Brazilian Journal of Medical and Biological Research;journal;0100879X, 1414431X;0.424;Q1;91;182;568;5940;824;564;1.3;32.64;Brazil;Latin America;Associacao Brasileira de Divulgacao Cientifica;1973-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Biochemistry (Q3); Biophysics (Q3); Immunology (Q3); Neuroscience (miscellaneous) (Q3); Cell Biology (Q4); Physiology (Q4)"
308;145580;International Journal of Peptide Research and Therapeutics;journal;15733149, 15733904;0.423;Q3;38;34;148;1099;155;146;0.99;32.32;Netherlands;Western Europe;Springer Netherlands;1996-2002, 2005-2021;"Analytical Chemistry (Q3); Biochemistry (Q3); Bioengineering (Q3); Drug Discovery (Q3); Molecular Medicine (Q3)"
309;21273;Journal of Immune Based Therapies and Vaccines;journal;14768518;0.419;Q3;21;5;26;216;38;26;1.74;43.2;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2011;"Immunology (Q3); Pharmacology (Q3)"
310;19958;Archives of Pharmacal Research;journal;19763786, 02536269;0.409;Q3;93;232;659;6581;908;659;1.35;28.37;South Korea;Asiatic Region;Pharmaceutical Society of Korea;1978-2021;"Drug Discovery (Q3); Molecular Medicine (Q3); Organic Chemistry (Q3)"
311;23348;Journal of Environmental Biology;journal;23940379, 02548704;0.409;Q3;51;186;485;6150;617;456;1.36;33.06;India;Asiatic Region;Triveni Enterprises;1988-2021;"Environmental Engineering (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
312;19398;Acta Pharmaceutica;journal;18469558, 13300075;0.405;Q2;60;40;120;708;218;120;1.75;17.7;Croatia;Eastern Europe;Croatian Pharmaceutical Society;1986, 1992-2022;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q3)"
313;145524;Drug Discovery Today: Disease Mechanisms;journal;17406765;0.4;Q3;27;9;154;431;114;140;0.9;47.89;United Kingdom;Western Europe;Elsevier Ltd.;2004-2013;"Drug Discovery (Q3); Molecular Medicine (Q3)"
314;15300154846;Journal of Occupational Medicine and Toxicology;journal;17456673;0.394;Q3;42;33;88;946;173;88;1.55;28.67;United Kingdom;Western Europe;BioMed Central Ltd.;2006-2021;"Public Health, Environmental and Occupational Health (Q2); Safety Research (Q2); Toxicology (Q3)"
315;29947;Journal of Chemotherapy;journal;1120009X, 19739478;0.393;Q3;52;131;448;3318;456;401;1.14;25.33;United Kingdom;Western Europe;Maney Publishing;1989-2021;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Infectious Diseases (Q3); Oncology (Q3); Pharmacology (Q3)"
316;27210;In Vivo;journal;17917549, 0258851X;0.392;Q3;64;154;452;4885;593;450;1.29;31.72;Greece;Western Europe;International Institute of Anticancer Research;1987-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
317;20766;Drug and Chemical Toxicology;journal;01480545, 15256014;0.389;Q3;46;57;103;1903;154;103;1.51;33.39;United States;Northern America;Informa Healthcare;1977-2021;"Chemical Health and Safety (Q1); Medicine (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
318;21100389517;Drug Metabolism and Personalized Therapy;journal;23638907, 23638915;0.387;Q1;36;17;42;640;58;40;1.53;37.65;Germany;Western Europe;Walter de Gruyter GmbH;2015-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2)"
319;26766;ATLA Alternatives to Laboratory Animals;journal;02611929;0.386;Q3;61;99;236;2751;263;180;1.01;27.79;United Kingdom;Western Europe;FRAME;1982, 1985-1986, 1988-1989, 1994-2021;"Medical Laboratory Technology (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q3)"
320;4700152426;Current Pharmaceutical Analysis;journal;15734129;0.382;Q2;25;36;87;3007;106;87;1.04;83.53;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Pharmaceutical Science (Q2); Biochemistry (Q3); Biophysics (Q3); Molecular Medicine (Q3)"
321;24071;Metal-Based Drugs;journal;07930291, 16875486;0.378;Q3;38;3;23;94;40;21;1.74;31.33;United States;Northern America;Hindawi Publishing Corporation;1996-2002, 2007-2011;"Drug Discovery (Q3); Inorganic Chemistry (Q3); Pharmacology (Q3); Toxicology (Q3)"
322;19927;Methods and Findings in Experimental and Clinical Pharmacology;journal;03790355;0.378;Q3;53;61;222;3529;287;220;1.22;57.85;Spain;Western Europe;Prous Science;1979-2010;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
323;19447;Journal of the American Pharmacists Association : JAPhA;journal;15443191, 15443450;0.375;Q3;67;133;355;2734;312;323;0.71;20.56;United States;Northern America;American Pharmacists Association;2003-2021;"Pharmacology (nursing) (Q1); Pharmacy (Q1); Pharmacology (Q3)"
324;29634;Journal of Negative Results in BioMedicine;journal;14775751;0.372;Q1;23;12;41;409;76;41;1.32;34.08;United Kingdom;Western Europe;BioMed Central Ltd.;2002-2017;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2)"
325;20066;Biopharmaceutics and Drug Disposition;journal;1099081X, 01422782;0.369;Q2;61;52;164;1637;260;164;1.46;31.48;United Kingdom;Western Europe;John Wiley and Sons Ltd;1979-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
326;11000153762;Journal of Immunotoxicology;journal;1547691X, 15476901;0.367;Q3;40;33;111;1274;133;110;1.27;38.61;United States;Northern America;Informa Healthcare;2004-2021;"Toxicology (Q3); Immunology (Q4)"
327;21100218041;Anti-Infective Agents;journal;22113533, 22113525;0.364;Q3;24;25;77;2808;81;74;1.16;112.32;United Arab Emirates;Middle East;Bentham Science Publishers;2012-2021;"Infectious Diseases (Q3); Pharmacology (Q3)"
328;18800156720;Dissolution Technologies;journal;1521298X;0.364;Q2;34;26;57;382;37;44;0.55;14.69;United States;Northern America;Dissolution Technologies Inc;1996-2021;Pharmaceutical Science (Q2)
329;25223;Toxicology and Industrial Health;journal;07482337, 14770393;0.356;Q3;62;84;155;3167;176;151;0.99;37.7;United Kingdom;Western Europe;SAGE Publications Ltd;1985-2021;"Health, Toxicology and Mutagenesis (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
330;23489;Chemical Speciation and Bioavailability;journal;09542299;0.351;Q3;0;0;0;0;0;0;0;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1989-2018;"Chemical Health and Safety (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
331;4700152233;Therapeutics and Clinical Risk Management;journal;11766336;0.351;Q1;59;101;319;5725;434;307;1.4;56.68;New Zealand;Pacific Region;Dove Medical Press Ltd.;2006-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Chemical Health and Safety (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Safety Research (Q2)"
332;130016;Cutaneous and Ocular Toxicology;journal;15569527, 15569535;0.348;Q3;32;32;92;901;121;91;1.39;28.16;United Kingdom;Western Europe;Informa Healthcare;1982-2000, 2005-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
333;22392;Indian Journal of Pharmaceutical Sciences;journal;0250474X, 19983743;0.347;Q2;61;149;620;2725;623;617;0.78;18.29;India;Asiatic Region;Wolters Kluwer Medknow Publications;1978-2021;Pharmaceutical Science (Q2)
334;20545;PDA Journal of Pharmaceutical Science and Technology;journal;19482124, 10797440;0.346;Q2;40;54;137;1149;114;131;0.86;21.28;United States;Northern America;Parenteral Drug Association Inc.;1994-2021;Pharmaceutical Science (Q2)
335;5800173386;Current Drug Safety;journal;15748863;0.343;Q3;37;34;96;1708;174;93;1.79;50.24;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Pharmacology (medical) (Q2); Pharmacology (Q3); Toxicology (Q3)"
336;21717;Die Pharmazie;journal;00317144;0.338;Q2;66;162;615;3868;633;612;1.03;23.88;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1947-2021;Pharmaceutical Science (Q2)
337;19300156901;Dose-Response;journal;15593258;0.333;Q3;41;19;21;1289;31;21;1.48;67.84;United States;Northern America;International Dose-Response Society;2008-2021;"Chemical Health and Safety (Q3); Health, Toxicology and Mutagenesis (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
338;4700151615;Scandinavian Journal of Work, Environment and Health, Supplement;journal;03566528;0.333;Q3;23;13;86;307;70;76;0.55;23.62;Finland;Western Europe;Finnish Institute of Occupational Health;2005-2011, 2016-2018;"Geography, Planning and Development (Q2); Health, Toxicology and Mutagenesis (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
339;22456;International Journal of Pharmacy Practice;journal;09617671, 20427174;0.332;Q2;39;62;205;1368;102;188;0.38;22.06;United Kingdom;Western Europe;Oxford University Press;1991-2021;"Pharmacy (Q1); Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Public Health, Environmental and Occupational Health (Q3)"
340;19444;American Journal of Pharmaceutical Education;journal;15536467, 00029459;0.331;Q2;69;170;422;2949;460;391;1;17.35;United States;Northern America;American Association of Colleges of Pharmacy;1945-1948, 1973-1989, 1991, 1996-2021;"Education (Q2); Medicine (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)"
341;21246;International Journal of Immunopathology and Pharmacology;journal;03946320;0.331;Q3;58;150;379;3944;839;368;2.52;26.29;Italy;Western Europe;SAGE Publications Inc.;1989-2021;"Immunology and Allergy (Q3); Pharmacology (Q3); Immunology (Q4)"
342;10900153328;Frontiers in Drug Design and Discovery;book series;15740889, 22121064;0.33;Q2;9;18;41;2204;31;39;1.09;122.44;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2007, 2009, 2016-2018;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Molecular Medicine (Q3)"
343;21082;Pharmaceutical Biology;journal;13880209, 17445116;0.328;Q2;72;188;370;5474;378;369;0.88;29.12;United Kingdom;Western Europe;Taylor and Francis Ltd.;1961-1972, 1975-2021;"Complementary and Alternative Medicine (Q1); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
344;5400152628;Revista Brasileira de Farmacognosia;journal;0102695X, 1981528X;0.326;Q2;50;154;216;4842;646;207;2.99;31.44;Brazil;Latin America;Springer Nature Switzerland AG;2007-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
345;15340;Developments in Biologicals;journal;14246074, 16622960;0.325;Q3;38;0;366;0;327;359;0.66;0;Switzerland;Western Europe;S. Karger AG;2000-2008, 2010, 2012-2013;"Pharmacology (Q3); Biomaterials (Q4); Immunology (Q4)"
346;3500148011;Journal of Zhejiang University: Science B;journal;16731581;0.325;Q2;61;130;432;3850;574;424;1.31;29.62;China;Asiatic Region;Zhejiang University Press;2005-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Veterinary (miscellaneous) (Q2)"
347;10300153342;Journal of Medical Toxicology;journal;15569039, 19376995;0.324;Q3;52;55;134;978;127;114;0.96;17.78;United States;Northern America;Springer New York;2005-2021;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
348;22372;Immunopharmacology and Immunotoxicology;journal;15322513, 08923973;0.321;Q3;53;97;170;3706;177;169;0.89;38.21;United Kingdom;Western Europe;Informa Healthcare;1978-2021;"Medicine (miscellaneous) (Q2); Immunology and Allergy (Q3); Pharmacology (Q3); Toxicology (Q3); Immunology (Q4)"
349;37697;Autonomic and Autacoid Pharmacology;journal;14748673, 14748665;0.319;Q3;21;17;103;935;88;102;1.03;55;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2002-2017;Pharmacology (Q3)
350;21811;Farmacia Hospitalaria;journal;21718695, 11306343;0.317;Q3;24;70;238;1168;121;90;0.39;16.69;Spain;Western Europe;Grupo Aula Medica S.A.;1990-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
351;4100151616;Supportive Cancer Therapy;journal;15432912;0.314;Q3;14;0;66;0;69;55;1.32;0;United States;Northern America;Cancer Information Group, LP;2006-2007;"Oncology (Q3); Pharmacology (Q3); Cancer Research (Q4)"
352;5800173401;Current Bioactive Compounds;journal;15734072;0.313;Q2;27;28;42;2102;43;38;1.02;75.07;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
353;4700151922;Research in Social and Administrative Pharmacy;journal;15517411;0.313;Q2;54;41;97;1374;90;93;0.92;33.51;United States;Northern America;Elsevier Inc.;2005-2021;"Pharmacy (Q1); Pharmaceutical Science (Q2)"
354;4700152608;African Journal of Traditional, Complementary and Alternative Medicines (discontinued);journal;25050044, 01896016;0.311;Q3;48;52;149;1369;114;144;0.63;26.33;Nigeria;Africa;African Ethnomedicines Network;2006-2017;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
355;17700155034;Natural Product Communications;journal;15559475, 1934578X;0.311;Q3;50;332;681;9136;533;670;0.78;27.52;United States;Northern America;SAGE Publications Inc.;2006-2022;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Plant Science (Q3)"
356;35190;Revista Espanola de Quimioterapia;journal;02143429;0.311;Q3;26;46;144;1111;109;130;0.67;24.15;Spain;Western Europe;Sociedad Espanola de Quiminoterapia;1989-2021;"Medicine (miscellaneous) (Q3); Microbiology (medical) (Q3); Pharmacology (Q3)"
357;25144;Journal of Health Science;journal;13475207, 13449702;0.308;Q4;49;133;347;3912;303;347;0.79;29.41;Japan;Asiatic Region;Pharmaceutical Society of Japan;1999-2011;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q4)"
358;25171;Mycotoxin Research;journal;18671632, 01787888;0.306;Q4;40;31;101;1041;85;89;0.64;33.58;Germany;Western Europe;Springer-Verlag GmbH and Co. KG;1985-2021;"Biotechnology (Q3); Microbiology (Q3); Toxicology (Q4)"
359;20710;DARU, Journal of Pharmaceutical Sciences;journal;15608115, 20082231;0.302;Q3;47;57;133;1467;101;133;0.67;25.74;United Kingdom;Western Europe;BioMed Central Ltd.;2000-2021;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
360;21208;Drug Discovery Today: Therapeutic Strategies;journal;17406773;0.3;Q3;29;22;165;901;123;150;0.46;40.95;United Kingdom;Western Europe;Elsevier Ltd.;2004-2013;"Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
361;4700152769;Pharmacopeial Forum (discontinued);journal;03634655;0.298;Q3;19;24;35;218;21;35;0.91;9.08;United States;Northern America;United States Pharmacopeial Convention Inc.;1996-1998, 2000-2018;"Pharmacy (Q1); Drug Guides (Q3); Pharmacology (Q3)"
362;20065;BioPharm International;trade journal;1542166X, 19391862;0.297;Q2;29;102;379;441;128;327;0.37;4.32;United States;Northern America;Advanstar Communications Inc.;2002-2020;"Pharmaceutical Science (Q2); Biotechnology (Q3)"
363;19700180781;Strategies and Tactics in Organic Synthesis;book series;18746004;0.296;Q3;10;0;15;0;4;13;0.27;0;United States;Northern America;Academic Press Inc.;2004-2005, 2008, 2012-2017, 2019;"Drug Discovery (Q3); Organic Chemistry (Q3)"
364;24097;Journal of the Indian Chemical Society;journal;00194522;0.29;Q3;33;235;757;4969;322;749;0.4;21.14;India;Asiatic Region;Elsevier BV;1973-1985, 1987-1991, 1996-2021;"Drug Discovery (Q3); Electrochemistry (Q3); Inorganic Chemistry (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3)"
365;34545;Journal of Asian Natural Products Research;journal;10286020, 14772213;0.289;Q2;42;162;444;2375;283;444;0.6;14.66;United Kingdom;Western Europe;Taylor and Francis Ltd.;1998-2021;"Complementary and Alternative Medicine (Q2); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Organic Chemistry (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
366;24043;Journal of Labelled Compounds and Radiopharmaceuticals;journal;03624803, 10991344;0.286;Q3;48;87;440;1837;312;435;0.68;21.11;United Kingdom;Western Europe;John Wiley and Sons Ltd;1976-2021;"Analytical Chemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Radiology, Nuclear Medicine and Imaging (Q3); Biochemistry (Q4); Spectroscopy (Q4)"
367;20578;Journal of Food and Drug Analysis;journal;10219498;0.284;Q3;63;59;199;1631;128;197;0.62;27.64;Taiwan;Asiatic Region;National Laboratories of Foods and Drugs;1994-2021;"Food Science (Q3); Pharmacology (Q3)"
368;110097;Food and Drug Law Journal;journal;1064590X;0.282;Q3;22;32;115;5476;46;115;0.42;171.13;United States;Northern America;Food and Drug Law Institute;1992-2018, 2021;"Law (Q2); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Public Health, Environmental and Occupational Health (Q3)"
369;130038;Letters in Drug Design and Discovery;journal;15701808;0.281;Q2;35;98;299;2524;223;299;0.83;25.76;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2005-2021;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Molecular Medicine (Q4)"
370;22204;Journal of Drug Delivery Science and Technology;journal;17732247, 25888943;0.276;Q2;52;57;198;2429;118;196;0.59;42.61;France;Western Europe;Editions de Sante;2004-2021;Pharmaceutical Science (Q2)
371;21265;Drugs of the Future;journal;03778282;0.275;Q3;45;111;357;7063;245;356;0.59;63.63;Spain;Western Europe;Prous Science;1978-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
372;19383;Fluoride - Quarterly Reports;journal;22534083, 00154725;0.272;Q4;48;42;143;1130;165;138;0.93;26.9;New Zealand;Pacific Region;International Society for Fluoride Research;1973-2021;"Agricultural and Biological Sciences (miscellaneous) (Q2); Chemistry (miscellaneous) (Q3); Dentistry (miscellaneous) (Q3); Public Health, Environmental and Occupational Health (Q3); Biochemistry (Q4); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
373;25241;Toxicology Mechanisms and Methods;journal;15376524, 15376516;0.272;Q4;46;79;218;2741;194;213;0.89;34.7;United Kingdom;Western Europe;Informa Healthcare;1991-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
374;21100470510;Drug Research;journal;21949379, 21949387;0.271;Q3;65;115;403;2261;309;398;0.72;19.66;Germany;Western Europe;Thieme;1972, 2013-2021;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
375;24111;Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry;journal;03764699, 09750983;0.27;Q2;48;157;627;3919;338;624;0.5;24.96;India;Asiatic Region;Scientific Publishers of India;1970, 1973-1978, 1981, 1989-1991, 1996-2018, 2020-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Organic Chemistry (Q4)"
376;21211;Pharmacy Education;journal;14772701, 15602214;0.269;Q2;18;10;92;164;47;92;0.47;16.4;Netherlands;Western Europe;;1973-1978, 2002-2021;"Pharmaceutical Science (Q2); Pharmacy (Q2); Education (Q3)"
377;73430;Pharmaceutical Technology;journal;15432521;0.268;Q2;38;184;561;721;115;433;0.19;3.92;United States;Northern America;Advanstar Communications Inc.;1979-1985, 1987, 1996-2021;"Pharmaceutical Science (Q2); Biophysics (Q4)"
378;19400157146;Food Additives and Contaminants: Part B Surveillance;journal;19393210, 19393229;0.267;Q4;32;25;22;652;16;21;0.73;26.08;United Kingdom;Western Europe;Taylor and Francis Ltd.;2008-2021;"Food Science (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q4)"
379;16698;Revista Brasileira de Plantas Medicinais;journal;1983084X, 15160572;0.267;Q3;29;69;154;1868;69;154;0.36;27.07;Brazil;Latin America;Instituto de Biociencias;1999-2016;"Complementary and Alternative Medicine (Q2); Pharmacology (Q3)"
380;21328;European Journal of Drug Metabolism and Pharmacokinetics;journal;21070180, 03787966;0.265;Q3;39;34;96;710;79;94;0.82;20.88;France;Western Europe;Springer Paris;1976-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
381;20564;Ceska a Slovenska Farmacie;journal;12107816;0.264;Q2;17;37;131;828;55;128;0.46;22.38;Czech Republic;Eastern Europe;Czech Medical Association J.E. Purkyne;1994-2021;Pharmaceutical Science (Q2)
382;144963;Drug Discovery Today: Disease Models;journal;17406757;0.264;Q3;28;22;137;950;66;121;0.38;43.18;United Kingdom;Western Europe;Elsevier Ltd.;2004-2020;"Drug Discovery (Q3); Molecular Medicine (Q4)"
383;21207;Drug Discovery Today: Technologies;journal;17406749;0.264;Q3;53;6;103;222;93;93;0.23;37;United Kingdom;Western Europe;Elsevier Ltd.;2004-2021;"Biotechnology (Q3); Drug Discovery (Q3); Molecular Medicine (Q4)"
384;22881;Yaoxue Xuebao;journal;05134870;0.254;Q2;34;244;688;4732;388;688;0.58;19.39;China;Asiatic Region;Chinese Pharmaceutical Association;1960, 1962-1966, 1979-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Molecular Medicine (Q4)"
385;14500154702;Journal of Cardiovascular Translational Research;journal;19375395, 19375387;0.251;Q2;53;68;62;2852;18;55;0.29;41.94;United States;Northern America;Springer New York;2008-2021;"Pharmaceutical Science (Q2); Cardiology and Cardiovascular Medicine (Q3); Genetics (Q4); Genetics (clinical) (Q4); Molecular Medicine (Q4)"
386;22854;Yakugaku Zasshi;journal;13475231, 00316903;0.247;Q2;43;189;612;4511;436;591;0.64;23.87;Japan;Asiatic Region;Pharmaceutical Society of Japan;1961-2021;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
387;22393;Indian Journal of Pharmacology;journal;02537613, 19983751;0.245;Q3;62;80;277;1290;203;217;0.67;16.13;India;Asiatic Region;Wolters Kluwer Medknow Publications;1978-1980, 1982, 1984-1986, 1994-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
388;25110;International Journal of Medical Toxicology and Legal Medicine;journal;09720448;0.245;Q4;9;25;70;455;11;70;0.13;18.2;India;Asiatic Region;All India Institute of Medical Sciences;1999-2003, 2005-2011, 2017-2021;"Pathology and Forensic Medicine (Q3); Toxicology (Q4)"
389;4000152107;Journal of Venomous Animals and Toxins Including Tropical Diseases;journal;16789199;0.243;Q4;32;66;172;1905;90;159;0.52;28.86;United Kingdom;Western Europe;Centro de Estudos de Venenos e Animais Peconhentos;2006-2021;"Animal Science and Zoology (Q3); Infectious Diseases (Q3); Parasitology (Q4); Toxicology (Q4)"
390;4700152701;Pharmacy Practice;journal;1885642X, 18863655;0.241;Q3;28;35;97;908;61;97;0.52;25.94;Spain;Western Europe;Centro de Investigaciones y Publicaciones Farmaceuticas;2006-2021;"Pharmacy (Q2); Pharmaceutical Science (Q3)"
391;4800154015;S.T.P. Pharma Pratiques;journal;11571497;0.241;Q3;10;27;100;321;14;99;0.15;11.89;France;Western Europe;Editions de Sante;1991-2014, 2017-2018;Pharmaceutical Science (Q3)
392;21102;Pharmaceutical Journal;journal;00316873;0.239;Q3;28;1044;3204;972;146;763;0.03;0.93;United Kingdom;Western Europe;Pharmaceutical Press;1945-1949, 1994-2012, 2014-2017;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
393;130045;Journal of Applied Biomedicine;journal;12140287, 1214021X;0.235;Q2;33;20;73;1174;83;73;1.08;58.7;Spain;Western Europe;Elsevier Espana;2005-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Agricultural and Biological Sciences (miscellaneous) (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Neuroscience (miscellaneous) (Q4)"
394;4000148204;Pakistan Journal of Pharmaceutical Sciences;journal;1011601X;0.232;Q3;42;75;199;2298;161;197;0.8;30.64;Pakistan;Asiatic Region;Pakistan Journal of Pharmaceutical Sciences;1995, 2005-2021;Pharmaceutical Science (Q3)
395;50105;Japanese Journal of Neuropsychopharmacology;journal;03887588, 13434144;0.231;Q3;11;27;90;718;39;90;0.45;26.59;Japan;Asiatic Region;Japanese Society of Neuropsychopharmacology;1982-1997, 2002-2017;"Clinical Psychology (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3); Psychiatry and Mental Health (Q3)"
396;79053;Natural Product Sciences;journal;12263907;0.231;Q3;28;46;174;1022;74;174;0.4;22.22;South Korea;Asiatic Region;Korean Society of Pharmacognosy;1997-2021;"Drug Discovery (Q3); Organic Chemistry (Q4)"
397;21496;Revista de Chimie (discontinued);journal;00347752;0.228;-;31;280;860;4964;402;860;0.54;17.73;Romania;Eastern Europe;Syscom 18 SRL;1973, 1996-2021;Chemistry (miscellaneous) (Q3)
398;11100153314;Frontiers in Medicinal Chemistry;book series;18755763, 15742042;0.226;Q3;7;29;27;4600;13;26;0;158.62;Netherlands;Western Europe;Bentham Science Publishers B.V.;2006, 2009-2010;"Drug Discovery (Q3); Molecular Medicine (Q4); Organic Chemistry (Q4)"
399;23440;Indian Journal of Physiology and Pharmacology;journal;00195499;0.222;Q3;53;56;189;1367;112;152;0.48;24.41;India;Asiatic Region;Association of Physiologists and Pharmacologists of India;1959-2021;"Pharmacology (Q3); Physiology (medical) (Q3); Physiology (Q4)"
400;4500151530;Personalized Medicine;journal;17410541;0.222;Q3;33;69;173;2470;107;146;0.67;35.8;United Kingdom;Western Europe;Future Medicine Ltd.;2006-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
401;22357;IDrugs : the investigational drugs journal;journal;13697056, 20403410;0.22;Q3;35;159;519;1324;259;519;0.51;8.33;United Kingdom;Western Europe;Current Drugs Ltd.;1998-2010;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
402;21828;Revista Cubana de Farmacia;journal;00347515, 15612988;0.22;Q3;9;55;114;807;15;106;0.18;14.67;Cuba;Latin America;Editorial Ciencias Medicas;1980-1991, 1996-2000, 2002, 2004-2021;"Pharmacy (Q2); Pharmaceutical Science (Q3); Pharmacology (Q3)"
403;22908;Chinese Pharmacological Bulletin;journal;10011978;0.217;Q3;17;440;1148;6331;783;1148;0.74;14.39;China;Asiatic Region;Institute of Clinical Pharmacology;1993-2020;Pharmacology (Q3)
404;19200156945;Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas;journal;07177917;0.216;Q3;22;70;40;1918;18;33;0.45;27.4;Chile;Latin America;MS-Editions;2008-2021;"Complementary and Alternative Medicine (Q2); Pharmacology (Q3); Plant Science (Q3); Drug Discovery (Q4)"
405;11200153563;Drug Metabolism Letters;journal;18740758, 18723128;0.216;Q3;28;40;101;1169;71;99;0.7;29.23;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2019, 2021;"Biochemistry (medical) (Q3); Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Clinical Biochemistry (Q4)"
406;25253;Blutalkohol (discontinued);journal;00065250;0.215;Q4;13;35;82;458;22;77;0.25;13.09;Germany;Western Europe;Steintor-Verlag GmbH;1974-2017, 2020-2021;"Medicine (miscellaneous) (Q3); Toxicology (Q4)"
407;17700156434;Current Pharmacogenomics and Personalized Medicine;journal;18756913, 18756921;0.213;Q3;19;27;26;2321;16;26;0.62;85.96;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2008-2018, 2020;"Pharmacology (Q3); Genetics (Q4); Genetics (clinical) (Q4); Molecular Biology (Q4); Molecular Medicine (Q4)"
408;11400153335;Recent Patents on Inflammation and Allergy Drug Discovery;journal;1872213X, 22122710;0.212;Q4;29;27;55;2785;42;55;0.76;103.15;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2020;"Immunology and Allergy (Q3); Medicine (miscellaneous) (Q3); Drug Discovery (Q4)"
409;3200147837;Journal of Exercise Science and Fitness;journal;1728869X;0.211;Q3;25;24;46;993;21;43;0.53;41.38;Singapore;Asiatic Region;Elsevier;2005-2021;"Pharmacology (nursing) (Q2); Pharmaceutical Science (Q3); Sports Science (Q4)"
410;26653;Journal of Herbal Pharmacotherapy;journal;15229106, 15228940;0.211;Q3;29;0;64;0;50;62;0.44;0;United States;Northern America;The Haworth Herbal Press;2001-2008;"Pharmacology (Q3); Biochemistry (Q4)"
411;5800173394;Current Drug Therapy;journal;15748855;0.209;Q2;17;27;50;1744;33;48;0.66;64.59;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
412;6400153143;Turkish Journal of Pharmaceutical Sciences;journal;1304530X;0.209;Q3;16;22;49;522;12;49;0.12;23.73;Turkey;Middle East;Turkish Pharmacists  Association;2006-2021;"Pharmaceutical Science (Q3); Molecular Medicine (Q4)"
413;22980;Journal of Basic and Clinical Physiology and Pharmacology;journal;21910286, 07926855;0.208;Q3;36;27;70;935;43;70;0.55;34.63;Germany;Western Europe;Walter de Gruyter GmbH;1985-1988, 1990-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Drug Discovery (Q4); Physiology (Q4)"
414;22375;Indian Drugs;journal;0019462X;0.207;Q3;31;142;453;2531;123;452;0.2;17.82;India;Asiatic Region;Indian Drug Manufacturers' Association;1989-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
415;19405;Acta Poloniae Pharmaceutica;journal;00016837;0.206;Q3;45;95;306;2209;166;306;0.5;23.25;Poland;Eastern Europe;Polish Pharmaceutical Society;1951-1955, 1961-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
416;4700152607;Current Enzyme Inhibition;journal;15734080;0.205;Q4;18;20;74;2319;44;74;0.69;115.95;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Biochemistry (Q4); Drug Discovery (Q4); Molecular Medicine (Q4)"
417;144613;Journal of Generic Medicines (discontinued);journal;17411343;0.205;Q3;15;35;128;470;29;119;0.13;13.43;United Kingdom;Western Europe;SAGE Publications Inc.;2003-2015, 2017, 2021;Pharmaceutical Science (Q3)
418;21083;Pharmaceutical Care Espana (discontinued);journal;11396202;0.204;Q3;9;26;84;430;10;68;0.09;16.54;Spain;Western Europe;Fundacion Pharamaceutical Care Espana;2001-2017;"Pharmacy (Q2); Pharmaceutical Science (Q3); Pharmacology (Q3)"
419;21758;Prescrire International;journal;11677422;0.203;Q3;13;216;527;1463;132;428;0.22;6.77;France;Western Europe;Association Mieux Prescrire;1996-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
420;19700182901;Brazilian Journal of Pharmaceutical Sciences;journal;19848250, 21759790;0.202;Q2;43;100;215;2962;103;206;0.29;29.62;Brazil;Latin America;Faculdade de Ciencias Farmaceuticas (Biblioteca-;2009-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
421;19500157062;Current Cardiovascular Risk Reports;journal;19329563, 19329520;0.2;Q3;30;66;155;2683;29;147;0.19;40.65;United States;Northern America;Current Medicine Group;2007-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
422;21810;Farmacia;journal;00148237;0.2;Q2;27;84;84;1293;53;84;0.63;15.39;Romania;Eastern Europe;Romanian Society for Pharmaceutical Sciences;1945-1946, 1973-1987, 2003, 2008-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
423;21100791826;Journal of Traditional Medicines;journal;18813747, 18801447;0.2;Q4;12;29;87;748;30;86;0.28;25.79;Japan;Asiatic Region;Medical and Pharmaceutical Society for WAKAN-YAKU;2004-2013;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q4)"
424;24605;Arhiv za Higijenu Rada i Toksikologiju;journal;18486312, 00041254;0.198;Q4;37;68;132;2394;78;132;0.8;35.21;Croatia;Eastern Europe;Institute for Medical Research and Occupational Health;1953-2021;"Public Health, Environmental and Occupational Health (Q3); Toxicology (Q4)"
425;21292;Epitheorese Klinikes Farmakologias kai Farmakokinetikes;journal;10116575;0.198;Q3;5;64;109;1577;15;109;0.16;24.64;Bulgaria;Eastern Europe;PHARMAKON-Press;1989-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
426;130072;International Journal of Medicinal Mushrooms;journal;15219437;0.197;Q3;33;42;104;1402;56;103;0.48;33.38;United States;Northern America;Begell House Inc.;2005-2021;"Applied Microbiology and Biotechnology (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
427;21100301409;Issues in Toxicology;book series;17577179, 17577187;0.197;Q3;16;18;51;1596;15;47;0.29;88.67;United Kingdom;Western Europe;Royal Society of Chemistry;2007-2021;"Pharmacology (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
428;21715;Pharmazeutische Industrie;journal;16167074, 0031711X;0.195;Q3;19;188;690;965;47;662;0.08;5.13;Germany;Western Europe;Editio Cantor Verlag GmbH;1960-1961, 1973-2019;Pharmaceutical Science (Q3)
429;59665;Chinese Journal of Natural Medicines;journal;16723651;0.194;Q4;40;78;305;1327;101;304;0.3;17.01;China;Asiatic Region;China Pharmaceutical University;2004-2021;"Complementary and Alternative Medicine (Q2); Medicine (miscellaneous) (Q3); Drug Discovery (Q4)"
430;21100463829;Chinese Journal of Population Resources and Environment;journal;23254262, 10042857;0.193;Q4;14;56;141;989;16;140;0.14;17.66;United Kingdom;Western Europe;Taylor and Francis Ltd.;1992, 2004-2013, 2015-2019;"Demography (Q3); Environmental Science (miscellaneous) (Q3); Toxicology (Q4)"
431;4600151507;Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry;journal;18715230;0.192;Q3;24;36;113;3866;39;101;0.23;107.39;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Immunology and Allergy (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Immunology (Q4)"
432;20599;Paediatric and Perinatal Drug Therapy;journal;14630095;0.192;Q3;19;0;59;0;37;50;0.7;0;United Kingdom;Western Europe;Librapharm;1997-2008;"Pediatrics, Perinatology and Child Health (Q3); Pharmacology (Q3)"
433;11200153304;Future HIV Therapy;journal;17469600, 17469619;0.191;Q3;8;0;57;0;20;46;0.35;0;United Kingdom;Western Europe;Future Medicine Ltd.;2008-2009;"Infectious Diseases (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3); Drug Discovery (Q4); Virology (Q4)"
434;58808;Pharmaceutical Care and Research;journal;16712838;0.191;Q3;8;167;386;1449;42;384;0.1;8.68;China;Asiatic Region;Publishing House of Pharmaceutical Care and Research;2004-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
435;4000148821;International Journal of Pharmaceutical Compounding;journal;10924221;0.19;Q3;11;155;352;1166;30;328;0.08;7.52;United States;Northern America;International Journal of Pharmaceutical Compounding;2006-2021;"Pharmacology (nursing) (Q2); Pharmacy (Q2); Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Pharmacology (medical) (Q3)"
436;130031;Journal of Toxicologic Pathology;journal;09149198;0.188;Q4;30;32;93;1336;36;93;0.38;41.75;Japan;Asiatic Region;Japanese Society of Toxicologic Pathology;1988-1990, 1992-2021;"Pathology and Forensic Medicine (Q3); Toxicology (Q4)"
437;11300153402;Biomarkers in Medicine;journal;17520363, 17520371;0.187;Q4;49;70;50;5373;29;41;0.58;76.76;United Kingdom;Western Europe;Future Medicine Ltd.;2008-2021;"Biochemistry (medical) (Q3); Clinical Biochemistry (Q4); Drug Discovery (Q4)"
438;21798;Farmaceutski Glasnik;journal;00148202;0.187;Q3;6;86;113;393;6;99;0.05;4.57;Croatia;Eastern Europe;Hrvatsko Farmaceutsko Drustvo;1950-1951, 1962, 1990-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
439;145689;Alimentary Pharmacology and Therapeutics Symposium Series;journal;17466334;0.186;Q2;9;0;56;0;20;56;0;0;United Kingdom;Western Europe;;2005-2007;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
440;4600151506;Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry;journal;18715222;0.184;Q3;14;27;125;2388;47;112;0.37;88.44;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2018;"Endocrinology, Diabetes and Metabolism (Q3); Pharmacology (Q3); Immunology and Allergy (Q4)"
441;18384;Medicinal Chemistry Research;journal;10542523, 15548120;0.184;Q2;50;65;276;1699;123;276;1.09;26.14;United States;Northern America;Birkhauser Boston;1994, 1996-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Organic Chemistry (Q4)"
442;19700180785;Studies in Natural Products Chemistry;book series;15725995;0.184;Q4;41;0;60;0;43;15;0.33;0;Netherlands;Western Europe;Elsevier;1995-1997, 2000-2003, 2005-2006, 2008, 2012-2021;"Drug Discovery (Q4); Organic Chemistry (Q4)"
443;17783;Research Communications in Molecular Pathology and Pharmacology;journal;10780297;0.182;Q3;39;6;18;0;13;18;0;0;United States;Northern America;PJD Publications Ltd;1994-2007, 2009;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
444;19446;American Pharmaceutical Review;journal;10998012;0.181;Q3;24;88;314;1412;96;313;0.27;16.05;United States;Northern America;Russell Publishing LLC;2002-2020;Pharmaceutical Science (Q3)
445;19888;Medical Letter on Drugs and Therapeutics;journal;0025732X, 15232859;0.18;Q3;20;91;207;510;80;204;0.38;5.6;United States;Northern America;Medical Letter Inc.;1965-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
446;9800153137;Trastornos Adictivos;journal;15750973;0.177;Q3;9;35;60;751;22;46;0.37;21.46;Spain;Western Europe;Ediciones Doyma, S.L.;2007-2012;"Pharmacology (Q3); Psychiatry and Mental Health (Q3)"
447;19381;Acta Farmaceutica Bonaerense;journal;03262383;0.175;Q3;0;0;0;0;0;0;0;0;Argentina;Latin America;Colegio de Farmaceuticos de la Provincia de Buenos Aires;1989-2006;"Pharmaceutical Science (Q3); Drug Discovery (Q4)"
448;23171;Korean Journal of Pharmacognosy;journal;02533073;0.175;Q3;17;64;189;1476;50;189;0.26;23.06;South Korea;Asiatic Region;Korean Society of Pharmacognosy;1990-2011, 2013-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
449;21100795043;Journal of Natural Remedies;journal;23203358, 09725547;0.172;Q3;22;34;107;690;26;107;0.18;20.29;India;Asiatic Region;Informatics Publishing Limited;2002-2021;Pharmacology (Q3)
450;4700152283;Revista de Ciencias Farmaceuticas Basica e Aplicada;journal;18084532;0.172;Q3;18;46;117;1370;31;117;0.27;29.78;Brazil;Latin America;Universidade Estadual Paulista - UNESP;2005-2021;Pharmaceutical Science (Q3)
451;22906;Journal of China Pharmaceutical University;journal;10005048;0.171;Q3;14;118;387;1596;80;387;0.22;13.53;China;Asiatic Region;China Pharmaceutical University;1989-1991, 2002-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
452;19461;Annales Pharmaceutiques Francaises;journal;00034509;0.167;Q3;27;57;149;1570;63;141;0.4;27.54;France;Western Europe;Elsevier Masson s.r.l.;1945, 1947-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
453;19600162009;Advances in Molecular Toxicology;book series;18720854, 22122044;0.166;Q3;15;8;14;942;10;12;0.88;117.75;Netherlands;Western Europe;Elsevier;2006, 2008-2018, 2020;"Pharmacology (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
454;22934;Chinese Pharmaceutical Journal;journal;10012494;0.166;Q3;21;517;1426;5723;269;1426;0.18;11.07;China;Asiatic Region;Chinese Pharmaceutical Association;1993-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
455;5700165173;Journal of Medical Marketing;journal;17457912, 17457904;0.164;Q2;19;44;143;730;30;120;0.22;16.59;United States;Northern America;SAGE Publications Inc.;2000-2015, 2017-2018;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Marketing (Q3); Medicine (miscellaneous) (Q3); Strategy and Management (Q3)"
456;5800179590;Pharmacologyonline (discontinued);journal;18278620;0.164;Q3;27;398;379;9952;146;379;0.39;25.01;Italy;Western Europe;SILAE - Societa Italo-Latinoamericana di Etnomedicina;2007-2021;"Pharmacology (Q3); Drug Discovery (Q4)"
457;3900148201;International Journal of Pharmacology (discontinued);journal;18125700, 18117775;0.163;Q4;39;58;301;1615;108;301;0.41;27.84;Pakistan;Asiatic Region;Asian Network for Scientific Information;2006-2018, 2020-2021;Pharmacology (Q4)
458;145096;Neuropsychopharmacologia Hungarica;journal;14198711;0.162;Q2;17;23;82;757;21;72;0.16;32.91;Hungary;Eastern Europe;Hungarian Association of Psychopharmacology;2004-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Neurology (clinical) (Q3); Neuropsychology and Physiological Psychology (Q4); Neuroscience (miscellaneous) (Q4)"
459;20684;Current Pharmacogenomics;journal;15701603;0.16;Q4;12;0;60;0;25;60;0.48;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2004-2007;"Genetics (Q4); Pharmacology (Q4)"
460;19700182122;Pharmaceuticals Policy and Law;journal;2210495X, 13892827;0.16;Q3;10;43;55;663;17;53;0.31;15.42;Netherlands;Western Europe;IOS Press BV;1999, 2001-2002, 2005, 2007-2018;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Health Policy (Q4)"
461;22937;Zhongguo Zhongyao Zazhi;journal;10015302;0.16;Q3;32;672;1665;7887;443;1665;0.22;11.74;China;Asiatic Region;Zhongguo Zhongyi Yanjiuyuan;1989-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
462;110141;Sangyo eiseigaku zasshi = Journal of occupational health;journal;13410725;0.159;Q4;14;10;48;52;16;48;0.3;5.2;Japan;Asiatic Region;Nihon Sangyo Eisei Gakkai;1995-2021;"Medicine (miscellaneous) (Q3); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
463;130089;Toxin Reviews;journal;15569543, 15569551;0.158;Q4;46;32;64;1815;35;60;0.51;56.72;United Kingdom;Western Europe;Informa Healthcare;1982-2021;Toxicology (Q4)
464;19700175230;Drug Design, Development and Therapy;journal;11778881;0.157;Q3;71;22;30;1112;11;27;0.37;50.55;New Zealand;Pacific Region;Dove Medical Press Ltd.;2007-2021;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
465;21795;Farmaceuticky Obzor (discontinued);journal;00148172;0.156;Q3;7;31;102;616;8;99;0.04;19.87;Slovakia;Eastern Europe;Postgraduate Medical and Pharmaceutical School;1961-1963, 1974, 1976-2016;Pharmaceutical Science (Q3)
466;21127;Pharmaceutical Technology Europe;journal;01646826;0.156;Q3;18;110;325;528;30;252;0.09;4.8;United States;Northern America;Advanstar Communications Inc.;1998-2020;Pharmaceutical Science (Q3)
467;19982;Asia Pacific Journal of Pharmacology;journal;02179687;0.155;Q4;9;0;10;0;3;9;0;0;Singapore;Asiatic Region;Singapore University Press;1986-1998, 2000-2001, 2003-2004, 2006;Pharmacology (Q4)
468;73076;Drug Discovery World;journal;14694344;0.155;Q4;13;50;103;393;28;93;0.31;7.86;United Kingdom;Western Europe;RJ Communications and Media Ltd.;2004-2018;Drug Discovery (Q4)
469;22338;Hospital Pharmacy;journal;19451253, 00185787;0.155;Q4;24;157;432;2002;67;384;0.16;12.75;United States;Northern America;Thomas Land Publishers Inc.;1973-2021;"Pharmacology (medical) (Q3); Pharmacy (Q3); Pharmacology (Q4)"
470;23074;Journal of Pharmaceutical Finance, Economics and Policy;journal;15385396, 15385698;0.152;Q3;7;0;52;0;11;40;0.13;0;United States;Northern America;Haworth Press Inc.;2003-2008;"Pharmaceutical Science (Q3); Health Policy (Q4); Pharmacology (Q4)"
471;10300153301;Expert Review of Clinical Pharmacology;journal;17512433, 17512441;0.151;Q3;46;58;71;5034;32;61;0.45;86.79;United Kingdom;Western Europe;Taylor and Francis Ltd.;2008-2021;"Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
472;19700189100;Pharmaceutical Medicine;journal;11782595, 11791993;0.149;Q4;19;36;141;566;52;126;0.4;15.72;United Kingdom;Western Europe;Adis International Ltd;2000-2001, 2008-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
473;5100152606;Biosciences Biotechnology Research Asia (discontinued);journal;09731245;0.148;Q4;18;152;402;2866;30;402;0.07;18.86;India;Asiatic Region;Oriental Scientific Publishing Company;2005-2016;"Agronomy and Crop Science (Q4); Biotechnology (Q4); Drug Discovery (Q4)"
474;13000154717;Current Topics in Toxicology;journal;09728228;0.148;Q4;7;5;11;240;4;11;0.36;48;India;Asiatic Region;Research Trends;2007-2009, 2011-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
475;20627;Clinical Research and Regulatory Affairs;journal;15322521, 10601333;0.147;Q3;17;12;37;303;11;37;0.25;25.25;United States;Northern America;Informa Healthcare;1983-1990, 1992-2016;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Pharmacology (Q4)"
476;12100156730;Pharmaceutische Weekblad Wetenschappelijk Platform;journal;18738982;0.146;Q4;2;0;10;0;2;10;0.2;0;Netherlands;Western Europe;Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP);2008, 2013-2015;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
477;19978;Ars Pharmaceutica (discontinued);journal;00042927;0.145;Q3;20;21;87;517;25;87;0.27;24.62;Spain;Western Europe;Universidad de Granada;1980-1981, 1983-1984, 1986-2001, 2003-2017, 2021;"History and Philosophy of Science (Q3); Pharmaceutical Science (Q3)"
478;17700156313;Iranian Journal of Pharmaceutical Research;journal;17350328, 17266890;0.145;Q3;48;47;127;942;41;115;0.35;20.04;Iran;Middle East;Iranian Journal of Pharmaceutical Research;2002-2021;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
479;22825;Proceedings of the Western Pharmacology Society;journal;00838969;0.145;Q4;24;36;114;592;33;114;0.4;16.44;United States;Northern America;Western Pharmacology Society;1960-1969, 1973-2011;Pharmacology (Q4)
480;145693;Canadian Pharmacists Journal;journal;17151635;0.143;Q3;24;84;372;836;32;210;0.08;9.95;Canada;Northern America;Canadian Pharmacists Association;2005-2021;"Pharmaceutical Science (Q3); Pharmacy (Q3)"
481;22205;Saudi Pharmaceutical Journal;journal;13190164;0.143;Q3;57;40;86;1135;30;86;0.31;28.38;Saudi Arabia;Middle East;King Saud University;1996-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
482;86349;Oral Therapeutics and Pharmacology;journal;02881012;0.142;Q4;5;13;42;252;5;41;0.13;19.38;Japan;Asiatic Region;Japanese Society of Oral Therapeutics and Pharmacology;1982-2021;"Pharmacology (medical) (Q3); Dentistry (miscellaneous) (Q4); Pharmacology (Q4)"
483;19600161802;International Journal of Computational Biology and Drug Design;journal;17560764, 17560756;0.141;Q4;14;25;30;759;9;30;0.3;30.36;United Kingdom;Western Europe;Inderscience Enterprises Ltd;2008-2021;"Computer Science Applications (Q4); Drug Discovery (Q4)"
484;21227;Pharmacy in Practice;journal;13581538;0.141;Q4;5;26;173;313;5;148;0.03;12.04;United Kingdom;Western Europe;Medicom Publishing;1995-2009;"Pharmacology (medical) (Q3); Pharmacy (Q3); Health Policy (Q4); Pharmacology (Q4)"
485;19700174889;Drug Target Insights;journal;11773928;0.14;Q3;13;1;14;45;4;14;0.29;45;Italy;Western Europe;AboutScience Srl;2008-2009, 2011-2020;"Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Clinical Biochemistry (Q4)"
486;19200156909;Indian Journal of Pharmaceutical Education and Research;journal;00195464;0.14;Q3;22;56;71;1064;14;67;0.2;19;India;Asiatic Region;Association of Pharmaceutical Teachers of India;2008-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
487;15240;Iranian Journal of Medical Sciences;journal;17353688, 02530716;0.14;-;31;51;174;1388;40;167;0.19;27.22;Iran;Middle East;Shiraz University of Medical Sciences;1979-1981, 1989-2021;Medicine (miscellaneous) (Q3)
488;10900153302;Biomarker Insights;journal;11772719;0.139;Q4;35;8;35;282;12;35;0.34;35.25;New Zealand;Pacific Region;Libertas Academica Ltd.;2008-2021;"Biochemistry (medical) (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
489;12328;Current Therapeutic Research;journal;0011393X, 18790313;0.139;Q4;42;40;112;1194;39;108;0.28;29.85;United States;Northern America;Elsevier Inc.;1959-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
490;11200153306;Journal of Pharmacology and Toxicology (discontinued);journal;1816496X, 2152100X;0.139;Q3;18;31;57;1027;20;57;0.35;33.13;United States;Northern America;Academic Journals Inc.;2008-2017;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
491;11900154394;Oriental Journal of Chemistry (discontinued);journal;0970020X, 22315039;0.139;Q4;27;218;211;3655;20;211;0.09;16.77;India;Asiatic Region;Bhopal, S.A. Iqbal;1989, 2008-2018, 2021;"Biochemistry (Q4); Chemistry (miscellaneous) (Q4); Drug Discovery (Q4); Environmental Chemistry (Q4)"
492;21086;Pharmaceutical Chemistry Journal;journal;15739031, 0091150X;0.139;Q4;34;161;489;2532;98;489;0.14;15.73;United States;Northern America;Springer New York;1967-2021;"Drug Discovery (Q4); Pharmacology (Q4)"
493;21412;Zeitschrift fur Phytotherapie : offizielles Organ der Ges. f. Phytotherapie e.V;journal;0722348X;0.139;Q4;13;68;201;912;38;119;0.2;13.41;Germany;Western Europe;Hippokrates Verlag GmbH;1982, 1985-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
494;19700180757;Advances in Phytomedicine;book series;1572557X;0.138;Q4;13;0;43;0;18;39;0;0;Netherlands;Western Europe;Elsevier;2002, 2006;"Drug Discovery (Q4); Plant Science (Q4)"
495;19700175819;Patient Preference and Adherence;journal;1177889X;0.138;Q3;54;40;68;1532;18;68;0.26;38.3;New Zealand;Pacific Region;Dove Medical Press Ltd.;2007-2021;"Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Social Sciences (miscellaneous) (Q3); Health Policy (Q4)"
496;22212;Scientia Pharmaceutica;journal;22180532, 00368709;0.138;Q3;46;52;76;1392;28;75;0.39;26.77;Switzerland;Western Europe;MDPI AG;1949, 1960-1961, 1973-2021;Pharmaceutical Science (Q3)
497;25247;Chinese Journal of Pharmacology and Toxicology;journal;10003002;0.137;Q4;12;72;230;1558;49;230;0.21;21.64;China;Asiatic Region;Chinese Journal of Pharmacology and Toxicology;1986-2020;"Pharmacology (Q4); Toxicology (Q4)"
498;25425;Journal of Herbs, Spices and Medicinal Plants;journal;15403580, 10496475;0.137;Q4;29;34;95;855;33;95;0.22;25.15;United States;Northern America;Taylor and Francis Ltd.;1992-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
499;22977;Journal de Pharmacie de Belgique;journal;00472166;0.135;Q3;12;33;74;509;12;70;0.13;15.42;Belgium;Western Europe;APB Algemene Pharmaceutische Bond;1946-2015;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Pharmacology (Q4)"
500;13718;Pharmaceutical Engineering;journal;02738139;0.135;Q3;16;50;164;352;12;146;0.07;7.04;United States;Northern America;Int. Society for Pharmaceutical Engineering, Inc.;1996-2018;Pharmaceutical Science (Q3)
501;19700181403;Pharmaceutical Outsourcing;journal;19453337, 19453345;0.135;Q3;6;46;118;182;7;118;0.07;3.96;United States;Northern America;Russell Publishing LLC;2010-2018, 2021;"Pharmaceutical Science (Q3); Health Policy (Q4)"
502;5400152620;American Journal of Pharmacology and Toxicology (discontinued);journal;15574970, 15574962;0.134;Q3;21;27;44;972;21;44;0.48;36;United States;Northern America;Science Publications;2007-2016;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
503;17700156431;Handbook of Analytical Separations;book series;15677192;0.134;Q3;12;0;32;0;6;0;0.19;0;Netherlands;Western Europe;Elsevier;2000-2001, 2003-2004, 2008, 2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Analytical Chemistry (Q4); Environmental Chemistry (Q4); Pathology and Forensic Medicine (Q4)"
504;4000151610;International Journal of Neuroprotection and Neuroregeneration;journal;17451183, 17451191;0.134;Q4;5;0;55;0;13;48;0.1;0;United Kingdom;Western Europe;RPA Publishers.;2006-2008;"Neurology (clinical) (Q4); Pharmacology (Q4)"
505;11100153311;Iranian Journal of Pharmacology and Therapeutics;journal;17352657;0.134;Q4;21;15;101;452;45;101;0.23;30.13;Iran;Middle East;Academy of Medical Sciences of I.R. Iran;2006-2015;Pharmacology (Q4)
506;19200156706;Pharmacognosy Magazine (discontinued);journal;09731296, 09764062;0.134;Q4;42;86;75;2026;30;71;0.4;23.56;India;Asiatic Region;Wolters Kluwer Medknow Publications;2008-2018, 2020-2021;"Drug Discovery (Q4); Pharmaceutical Science (Q4)"
507;130170;Phytotherapie;journal;17652847, 16248597;0.134;Q4;18;58;187;1059;25;137;0.13;18.26;France;Western Europe;Springer Paris;2005-2020;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
508;21800;Farmacevtski Vestnik (discontinued);journal;00148229;0.132;Q4;4;57;109;1275;8;106;0.09;22.37;Slovenia;Eastern Europe;Slovenian Pharmaceutical Society;1961, 1989-2016;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
509;18800156730;Biomolecules and Therapeutics;journal;19769148, 20054483;0.131;Q4;44;61;65;2033;18;65;0.28;33.33;South Korea;Asiatic Region;Korean Society of Applied Pharmacology;2008-2021;"Biochemistry (Q4); Drug Discovery (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
510;50087;EBR - European Biopharmaceutical Review;journal;13690663;0.131;Q4;5;64;246;456;5;242;0.02;7.13;United Kingdom;Western Europe;Samedan Ltd;2004-2019;Pharmaceutical Science (Q4)
511;22979;Journal of Applied Therapeutic Research;journal;10292659;0.131;Q4;8;10;21;215;8;21;0.44;21.5;United Kingdom;Western Europe;Euromed Communications;1998-2000, 2003-2012;Pharmacology (Q4)
512;80593;Journal of Medicinal Plants;journal;16840240;0.131;Q4;23;88;159;2257;30;159;0.15;25.65;Iran;Middle East;;2004-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
513;21718;Pharmazie in Unserer Zeit;journal;00483664, 16151003;0.131;Q4;13;89;243;1085;36;191;0.16;12.19;Germany;Western Europe;Wiley-VCH Verlag;1972-2012;"Pharmacology (medical) (Q3); Pharmaceutical Science (Q4); Pharmacology (Q4)"
514;70864;Anales de la Real Academia Nacional de Farmacia (discontinued);journal;1697428X, 16974271;0.13;Q4;10;29;104;1093;15;101;0.15;37.69;Spain;Western Europe;Real Academia Nacional de Farmacia;1988-2018;"Pharmacology (medical) (Q3); Cell Biology (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4)"
515;19700174893;Dhaka University Journal of Pharmaceutical Sciences (discontinued);journal;18161839, 18161820;0.13;Q4;13;29;58;482;18;58;0.31;16.62;Bangladesh;Asiatic Region;University of Dhaka;2007-2018, 2020;"Pharmacology (medical) (Q3); Pharmaceutical Science (Q4)"
516;19700175108;Drug Delivery System;journal;18812732, 09135006;0.13;Q4;8;29;88;706;11;88;0.12;24.34;Japan;Asiatic Region;Japan Society of Drug Delivery System;1986, 1988-2021;Pharmaceutical Science (Q4)
517;6800153106;International Journal of Essential Oil Therapeutics;journal;19614209;0.13;Q4;13;31;59;963;18;58;0.31;31.06;France;Western Europe;Essential Oil Resource Consultants;2007-2010;"Complementary and Alternative Medicine (Q3); Pharmacology (medical) (Q3); Pharmaceutical Science (Q4)"
518;23107;Journal of Pharmacy Technology;journal;15494810, 87551225;0.13;Q4;13;32;93;827;11;90;0.14;25.84;United States;Northern America;SAGE Publications Inc.;1989-2021;Pharmaceutical Science (Q4)
519;5200152602;Acta Pharmaceutica Sciencia;journal;13072080;0.129;Q4;20;36;55;696;5;55;0.11;19.33;Turkey;Middle East;Istanbul Medipol University;2006-2011, 2016-2021;Pharmaceutical Science (Q4)
520;19459;Ankara Universitesi Eczacilik Fakultesi Dergisi;journal;10153918;0.129;Q4;11;22;61;874;6;61;0.05;39.73;Turkey;Middle East;University of Ankara;1997-2001, 2003-2010, 2014, 2016-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
521;23009;Journal of Clinical Research;journal;13695207;0.129;Q4;11;2;6;23;1;6;0.25;11.5;United Kingdom;Western Europe;PJB Publications Ltd.;1998-2009;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
522;19700175149;African Journal Biomedical Research;journal;11195096;0.128;Q3;17;0;47;0;14;47;0.3;0;Nigeria;Africa;Ibadan Biomedical Communications Group;2008, 2010-2021;"Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
523;4900152705;NATO Security through Science Series A: Chemistry and Biology;book series;18714641;0.127;Q3;14;0;215;0;60;214;0.28;0;Germany;Western Europe;Springer Verlag;2006-2008;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biotechnology (Q4); Chemistry (miscellaneous) (Q4)"
524;4000148308;Chinese Traditional and Herbal Drugs;journal;02532670;0.126;Q4;17;309;950;4255;129;950;0.13;13.77;China;Asiatic Region;Editorial Office of Chinese Traditional and Herbal Drugs;2006-2021;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
525;10600153336;Innovations in Pharmaceutical Technology;trade journal;14717204;0.125;Q4;9;87;110;339;6;105;0.05;3.9;United Kingdom;Western Europe;Samedan Ltd;2007-2010, 2012-2019;Pharmaceutical Science (Q4)
526;22858;Japanese Pharmacology and Therapeutics;journal;03863603;0.125;Q4;16;90;302;1404;29;302;0.1;15.6;Japan;Asiatic Region;Life Science Publishing Co. Ltd;1981-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
527;21836;Revista Mexicana de Ciencias Farmaceuticas;journal;10273956;0.125;Q4;9;27;98;612;6;78;0.06;22.67;Mexico;Latin America;Asociacion Farmaceutica Mexicana A.C.;1997-2015;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
528;5900153315;Pharmacoeconomics - Spanish Research Articles;journal;1695405X;0.123;Q3;6;16;29;471;5;27;0.17;29.44;Switzerland;Western Europe;Springer Science + Business Media;2007-2018;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Health Policy (Q4)"
529;19400157518;Rasayan Journal of Chemistry;journal;09760083, 09741496;0.123;Q4;24;170;128;3313;28;128;0.22;19.49;India;Asiatic Region;Rasayan Journal;2008-2021;"Chemical Engineering (miscellaneous) (Q3); Energy (miscellaneous) (Q3); Biochemistry (Q4); Chemistry (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
530;5100152903;Revista Cubana de Plantas Medicinales;journal;10284796;0.123;Q4;14;34;69;585;8;60;0.13;17.21;Cuba;Latin America;Editorial Ciencias Medicas;1996-1997, 1999-2002, 2005-2020;"Drug Discovery (Q4); Pharmacology (Q4); Plant Science (Q4)"
531;18098;Japanese Journal of Psychopharmacology;journal;13402544;0.122;Q4;0;0;0;0;0;0;0;0;Japan;Asiatic Region;Japanese Society of Neuropsychopharmacology;1981-2016;"Clinical Psychology (Q4); Medicine (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
532;17716;Quality Assurance Journal;journal;10991786, 10878378;0.122;Q4;9;21;52;202;8;43;0.19;9.62;United Kingdom;Western Europe;John Wiley and Sons Ltd;1998, 2000-2007, 2009-2011;"Medicine (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
533;19700174969;Archives of Drug Information;journal;17535174;0.121;Q4;11;10;14;237;2;13;0.14;23.7;United States;Northern America;"John Wiley &amp; Sons Inc.";2008-2011;"Complementary and Alternative Medicine (Q3); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
534;21907;Journal of Anaesthesiology Clinical Pharmacology;journal;09709185, 22312730;0.121;Q4;35;162;339;2001;35;230;0.1;12.35;India;Asiatic Region;Wolters Kluwer Medknow Publications;1996-1999, 2002-2021;"Anesthesiology and Pain Medicine (Q3); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
535;11400153330;Recent Patents on Endocrine, Metabolic and Immune Drug Discovery;journal;18722148, 22123334;0.119;Q4;25;26;25;2466;5;25;0.2;94.85;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2008-2017;"Biochemistry (medical) (Q4); Drug Discovery (Q4); Endocrinology, Diabetes and Metabolism (Q4); Immunology and Allergy (Q4); Medicine (miscellaneous) (Q4)"
536;144879;Toxicology International;journal;09716580;0.119;Q4;28;15;70;279;8;70;0.1;18.6;India;Asiatic Region;Society of Toxicology India;2005-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
537;9100153105;Current Topics in Pharmacology;journal;09724559;0.118;Q4;6;15;52;1247;7;52;0.15;83.13;India;Asiatic Region;Research Trends;2006-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
538;15842;Journal of Applied Research;journal;1537064X;0.118;Q4;22;21;90;490;26;82;0.31;23.33;United States;Northern America;The Journal of Applied Research;2001-2014;"Medicine (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
539;21142;Pharmaceutisch Weekblad;journal;00316911;0.118;Q4;9;412;1485;539;20;791;0.02;1.31;Netherlands;Western Europe;Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP);1948-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
540;21100197929;Toxicological Research;journal;19768257, 22342753;0.118;Q4;35;34;42;1079;7;42;0.17;31.74;South Korea;Asiatic Region;Koreal Association of Medical Journal Editors;2008-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
541;22358;U.S. Pharmacist;trade journal;01484818;0.117;Q4;9;131;332;2225;32;311;0.1;16.98;United States;Northern America;Jobson Publishing Corporation;1979, 1990-1996, 2007-2021;"Pharmacy (Q3); Pharmaceutical Science (Q4); Pharmacology (Q4)"
542;23173;Korean Journal of Physiology and Pharmacology;journal;20933827, 12264512;0.116;Q4;33;74;143;2432;17;143;0.1;32.86;South Korea;Asiatic Region;Korean Physiological Soc. and Korean Soc. of Pharmacology;1997-2021;"Pharmacology (Q4); Physiology (Q4)"
543;21279;Eksperimental'naya i Klinicheskaya Farmakologiya;journal;08692092;0.114;Q4;15;86;282;782;32;281;0.09;9.09;Russian Federation;Eastern Europe;Izdatelstvo Meditsina;1992-2021;"Medicine (miscellaneous) (Q4); Pharmacology (Q4); Toxicology (Q4)"
544;5200152604;Pharma Times;journal;00316849;0.114;Q4;12;97;158;496;6;105;0.03;5.11;India;Asiatic Region;Indian Pharmaceutical Association;2006-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
545;4000151703;Core Evidence (discontinued);journal;15551741, 1555175X;0.113;Q4;25;21;36;1223;6;36;0.21;58.24;New Zealand;Pacific Region;Dove Medical Press Ltd.;2005-2018;"Reviews and References (medical) (Q1); Medicine (miscellaneous) (Q4); Pharmacology (Q4)"
546;19399;Acta Pharmaceutica Hungarica (discontinued);journal;00016659;0.112;Q4;14;20;73;687;13;73;0.14;34.35;Hungary;Eastern Europe;Magyar Gyogyszereszeti Tarsasag;1965-2018;"Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4)"
547;16893;Biogenic Amines;journal;15693910, 01688561;0.112;Q4;15;0;50;0;10;49;0.23;0;Slovenia;Eastern Europe;Society of Integrated Sciences;1989-2007;"Neuroscience (miscellaneous) (Q4); Pharmacology (Q4)"
548;21334;EPC - European Pharmaceutical Contractor;journal;1364369X;0.112;Q4;3;75;285;368;3;275;0.01;4.91;United Kingdom;Western Europe;Samedan Ltd;2002-2016;Pharmaceutical Science (Q4)
549;19700174992;European Journal of Oncology Pharmacy;journal;17833914;0.112;Q4;4;25;17;125;1;15;0.06;5;Belgium;Western Europe;Pharma Publishing and Media Europe;2008-2015, 2017-2019;"Oncology (Q4); Pharmacology (Q4)"
550;19400157142;Chiang Mai University Journal of Natural Sciences;journal;16851994;0.111;-;12;24;2;475;0;2;0;19.79;Thailand;Asiatic Region;Chiang Mai University;2003, 2006, 2009-2021;Multidisciplinary (Q4)
551;21374;Fabad Journal of Pharmaceutical Sciences;journal;13004182;0.111;Q4;18;24;73;1031;5;72;0.04;42.96;Turkey;Middle East;Society of Pharmaceutical Sciences of Ankara;1999-2001, 2003-2021;Pharmaceutical Science (Q4)
552;21797;Farmaceutisch Tijdschrift voor Belgie;journal;07712367;0.111;Q4;3;21;66;278;2;60;0.02;13.24;Belgium;Western Europe;APB Algemene Pharmaceutische Bond;1978-2013;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
553;21716;Pharmazeutische Zeitung;journal;00317136;0.111;Q4;7;496;1373;1397;24;547;0.01;2.82;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1947-1948, 1985-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
554;4100151606;Actualites Pharmaceutiques Hospitalieres;journal;17697344;0.11;Q4;3;30;123;426;3;102;0.03;14.2;France;Western Europe;Elsevier Masson s.r.l.;2005-2012;Pharmaceutical Science (Q4)
555;19700174886;Arzneimitteltherapie;journal;07236913;0.11;Q4;6;138;162;1012;8;69;0.05;7.33;Germany;Western Europe;Wissenschaftliche Verlagsgesellschaft Stuttgart;2008-2021;"Pharmacology (nursing) (Q3); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
556;22887;Chinese Journal of Antibiotics;journal;10018689;0.11;Q4;11;177;567;2119;31;566;0.06;11.97;China;Asiatic Region;Editorial Office of Chinese Journal of Antibiotics;1983-2015;Pharmacology (Q4)
557;19700174913;Therapeutic Advances in Neurological Disorders;journal;17562864, 17562856;0.11;Q4;56;33;18;2252;9;13;0.5;68.24;United Kingdom;Western Europe;SAGE Publications Ltd;2008-2021;"Neurology (Q4); Neurology (clinical) (Q4); Pharmacology (Q4)"
558;19700174892;Chinese Journal of Cancer Biotherapy;journal;1007385X;0.109;Q4;5;131;129;2871;9;126;0.07;21.92;China;Asiatic Region;Editorial office of Chinese Journal of Cancer Biotherapy;2008-2011, 2013-2016, 2018-2022;"Cancer Research (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
559;11800154521;ICBPE 2006 - Proceedings of the 2006 International Conference on Biomedical and Pharmaceutical Engineering;conference and proceedings;-;0.109;-;9;0;124;0;15;123;0;0;United States;Northern America;;;"Biomedical Engineering; Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
560;22514;Japanese Journal of Chemotherapy;journal;13407007;0.109;Q4;12;50;128;772;10;128;0.05;15.44;Japan;Asiatic Region;Japan Society of Chemotherapy;1995-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
561;12100156823;5th PCIC Europe 2008: Petroleum and Chemical Industry Conference Europe;conference and proceedings;-;0.108;-;5;0;29;0;5;28;0.17;0;United States;Northern America;;;"Chemical Engineering (miscellaneous); Electrical and Electronic Engineering; Geochemistry and Petrology; Pharmaceutical Science"
562;21100829255;Chinese Journal of Pharmaceutical Biotechnology;journal;10058915;0.108;Q4;5;111;199;1481;11;199;0.06;13.34;China;Asiatic Region;China Pharmaceutical University;2007-2021;"Applied Microbiology and Biotechnology (Q4); Pharmaceutical Science (Q4)"
563;19700188399;Current protocols in toxicology / editorial board, Mahin D. Maines (editor-in-chief) ... [et al.];journal;19349254, 19349262;0.108;Q4;28;25;54;367;1;48;0.03;14.68;United States;Northern America;"John Wiley &amp; Sons Inc.";2001-2020;"Medicine (miscellaneous) (Q4); Toxicology (Q4)"
564;21243;Pharmacy Times;trade journal;00030627;0.108;Q4;8;213;461;702;16;407;0.03;3.3;United States;Northern America;Intellisphere LLC;1977-1987, 2007-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
565;19700174966;Pharmakeftiki;journal;22413081, 11054999;0.108;Q4;5;13;16;751;1;15;0.06;57.77;Greece;Western Europe;Zita Medical Managent;2008-2010, 2012-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
566;19700174922;Chinese Journal of New Drugs;journal;10033734;0.107;Q4;12;455;565;5114;28;565;0.05;11.24;China;Asiatic Region;Chinese Journal of New Drugs Co. Ltd.;2008-2021;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
567;10300153375;Taiwan Pharmaceutical Journal;journal;10161015;0.107;Q4;5;5;25;79;2;25;0.08;15.8;Taiwan;Asiatic Region;Pharmaceutical Society of Republic of China;2007, 2009;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
568;21840;Folia Pharmacologica Japonica;journal;00155691, 13478397;0.106;Q4;19;108;411;2036;24;407;0.05;18.85;Japan;Asiatic Region;Japanese Pharmacological Society;1944, 1947-1948, 1951-1956, 1958-2021;Pharmacology (Q4)
569;19700175031;Research Journal of Pharmacology (discontinued);journal;19936019, 18159362;0.106;Q4;9;12;12;400;3;12;0.25;33.33;Pakistan;Asiatic Region;Medwell Publishing;2008-2014, 2016;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
570;86688;Acta Toxicologica;journal;17316383;0.105;Q4;7;0;38;0;2;35;0.05;0;Poland;Eastern Europe;Nofer Institute of Occupational Medicine;2003-2007;Toxicology (Q4)
571;21100198011;Current Protocols in Pharmacology;journal;19348282, 19348290;0.105;Q4;34;20;58;834;5;55;0.09;41.7;United States;Northern America;"John Wiley &amp; Sons Inc.";2001-2020;"Medicine (miscellaneous) (Q4); Pharmacology (Q4)"
572;21867;Geneesmiddelenbulletin;journal;03044629;0.105;Q4;7;65;204;238;2;26;0.01;3.66;Netherlands;Western Europe;Stichting Geneesmiddelenbulletin;1973-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
573;72755;Phytomedica;journal;09723293;0.105;Q4;4;0;45;0;3;45;0;0;India;Asiatic Region;Society of Phytomedica;1999-2008;"Complementary and Alternative Medicine (Q4); Pharmacology (Q4)"
574;25196;Revista Brasileira de Toxicologia;journal;14152983;0.105;Q4;7;6;34;220;3;34;0.05;36.67;Brazil;Latin America;Sociedade Brasileira de Toxicologia;2000-2010;Toxicology (Q4)
575;17744;Anales de la Real Academia Nacional de Medicina;journal;00340634;0.104;Q4;6;29;128;0;7;128;0.03;0;Spain;Western Europe;Real Academia de Farmacia;1949-2012, 2014;"Cell Biology (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
576;5000158117;Profiles of Drug Substances, Excipients and Related Methodology;journal;18715125;0.104;Q4;21;5;9;374;1;3;0.11;74.8;United States;Northern America;Academic Press Inc.;2001-2003, 2005, 2007-2021;"Medicine (miscellaneous) (Q4); Molecular Medicine (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
577;21932;Hindustan Antibiotics Bulletin;journal;00181935;0.103;Q4;9;7;7;0;0;7;0;0;India;Asiatic Region;Hindustan Antibiotics Ltd.;1960-1961, 1965-2000, 2002-2003, 2005, 2007, 2009;Pharmacology (Q4)
578;13637;Manufacturing Chemist;trade journal;02624230;0.103;Q4;6;83;174;168;1;158;0.01;2.02;United Kingdom;Western Europe;Wilmington Publishing;1981-1984, 1986, 1989, 1996-2001, 2006-2021;Pharmaceutical Science (Q4)
579;19700174891;Perspectives in Medicinal Chemistry;journal;11773910, 1177391X;0.103;Q4;16;3;7;212;0;7;0;70.67;New Zealand;Pacific Region;Libertas Academica Ltd.;2008-2011, 2014-2016;"Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
580;21077;Pharmaca;journal;00316857;0.103;Q4;5;15;49;246;7;42;0.09;16.4;Croatia;Eastern Europe;Udruzenje Organizacija Zdravstva Hrvatske;1989-2011;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
581;19430;Adverse Drug Reaction Bulletin;journal;21597774, 00446394;0.102;Q4;7;6;18;231;2;18;0.08;38.5;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1970, 1973-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
582;21100239829;Current Issues in Pharmacy and Medical Sciences;journal;2084980X;0.102;Q4;10;93;0;1533;0;0;0;16.48;Poland;Eastern Europe;Uniwersytet Medyczny w Lublinie;2012-2021;"Biochemistry (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmacology (Q4)"
583;144718;Enhancer - Biotherapy of Cancer;journal;15720004;0.102;Q4;0;0;15;0;0;11;0;0;Netherlands;Western Europe;;2005-2006;"Cancer Research (Q4); Drug Discovery (Q4); Immunology (Q4); Immunology and Allergy (Q4); Oncology (Q4)"
584;19700174970;Hacettepe University Journal of the Faculty of Pharmacy;journal;13000608;0.102;Q4;7;13;12;458;0;12;0;35.23;Turkey;Middle East;Hacettepe University, Faculty of Pharmacy;2008-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
585;94365;Journal of Phytomedicine and Therapeutics;journal;11181028;0.102;Q4;6;11;9;212;4;9;0.44;19.27;Nigeria;Africa;National Institute for Pharmaceutical Research and Development;2000-2003, 2007, 2009, 2015-2016;Pharmacology (Q4)
586;19700182629;Methods in Pharmacology and Toxicology;book series;15572153, 19406053;0.102;Q4;10;0;22;0;1;21;0.05;0;United States;Northern America;Humana Press;2008, 2012, 2014-2021;"Molecular Medicine (Q4); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
587;89630;Psychopharmakotherapie, Supplement;journal;09465146;0.102;Q4;2;0;17;0;1;11;0.06;0;Germany;Western Europe;Wissenschaftliche Verlagsgesellschaft Stuttgart;1997-1999, 2004-2005, 2007-2008;"Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
588;145000;Signal;journal;14719967;0.102;Q4;1;0;12;0;0;10;0;0;United Kingdom;Western Europe;Adis International Ltd;2005-2007;"Drug Discovery (Q4); Oncology (Q4); Pharmacology (medical) (Q4)"
589;19700175137;Trends in Medical Research (discontinued);journal;18193587, 21516065;0.102;Q4;10;9;11;193;2;11;0.18;21.44;United States;Northern America;Academic Journals Inc.;2008-2016, 2020-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Medicine (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
590;27715;Anil Aggrawal's Internet Journal of Forensic Medicine and Toxicology;journal;09728074, 09728066;0.101;Q4;11;10;32;66;0;23;0;6.6;India;Asiatic Region;Anil Aggrawal;2000-2020;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
591;88685;Annual Report of Shionogi Research Laboratory;journal;05598680;0.101;Q4;2;11;18;0;0;17;0;0;Japan;Asiatic Region;Shionogi Co. Ltd;1972-1974, 1987-2009, 2015;Pharmacology (Q4)
592;9800153152;Archivos Venezolanos de Farmacologia y Terapeutica;journal;07980264;0.101;Q4;8;19;44;430;1;41;0.02;22.63;Venezuela;Latin America;Sociedad Latinoamericana de Hipertension;2007-2013, 2015-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
593;21100204921;Bulletin of Pharmaceutical Sciences;journal;11100052;0.101;Q4;8;23;25;653;1;25;0.04;28.39;Egypt;Africa/Middle East;Faculty of Pharmacy, Assiut University;2008-2014, 2018-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
594;9500153932;Ciencia y Tecnologia Pharmaceutica;journal;15753409;0.101;Q4;6;0;29;0;0;23;0;0;Spain;Western Europe;Fundacion Alimentacion Saludable;1996-2007;Pharmacology (Q4)
595;4700152278;Drugs in Context;journal;17404398, 17451981;0.101;Q4;26;0;79;0;1;62;0;0;United Kingdom;Western Europe;BioExcel Publishing Ltd.;2006-2008, 2012-2021;"Molecular Medicine (Q4); Pharmacology (Q4)"
596;21238;Drug Topics;journal;19378157, 00126616;0.101;Q4;8;133;1116;28;8;867;0.01;0.21;United States;Northern America;Advanstar Communications Inc.;1991, 1997-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
597;19200156912;EJHP Practice;trade journal;20303769, 17819989;0.101;Q4;6;123;25;766;1;22;0.04;6.23;Belgium;Western Europe;Pharma Publishing and Media Europe;2008-2011;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
598;78698;Japanese Journal of Clinical Pharmacology and Therapeutics;journal;18828272, 03881601;0.101;Q4;7;154;191;1051;5;187;0.03;6.82;Japan;Asiatic Region;Japanese Society of Clinical Pharmacology and Therapeutics;1970-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
599;19900191564;Journal of International Peacekeeping;journal;18754104, 18754112;0.101;Q4;10;10;22;605;2;20;0.08;60.5;Netherlands;Western Europe;Brill Academic Publishers;1995, 1997, 2001, 2004-2006, 2008-2011, 2013-2021;"Infectious Diseases (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Virology (Q4)"
600;15323;Journal of Jilin University Medicine Edition;journal;1671587X;0.101;Q4;7;283;840;3173;20;840;0.03;11.21;China;Asiatic Region;Jilin University Press;2005-2021;Pharmacology (Q4)
601;4700151603;Journal of Pharmacy of Istanbul University;journal;03677524;0.101;Q4;9;0;26;0;0;26;0;0;Turkey;Middle East;University of Istanbul;2005, 2007-2008, 2010, 2012, 2015-2016;"Pharmaceutical Science (Q4); Pharmacy (Q4)"
602;21823;Pharmacia;journal;04280296;0.101;Q4;16;11;46;208;1;46;0.04;18.91;Bulgaria;Eastern Europe;Pensoft Publishers;1945, 1954-1955, 1987-1991, 1997-2021;"Pharmaceutical Science (Q4); Pharmacology (medical) (Q4); Pharmacy (Q4)"
603;20572;PZ Prisma;journal;09455566;0.101;Q4;5;32;99;624;6;87;0.06;19.5;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1994-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
604;19408;Actualites Pharmaceutiques;journal;05153700;0.1;Q4;5;160;544;208;1;486;0;1.3;Netherlands;Western Europe;Elsevier;1961, 1963, 1996-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
605;20628;Circular Farmaceutica;journal;00097314;0.1;Q4;3;39;114;405;0;99;0;10.38;Spain;Western Europe;Col-legi de Farmaceutics de la Provincia de Barcelona;1961, 1973-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
606;5100154302;European Biotechnology Science and Industry News;journal;16188276;0.1;Q4;2;36;231;72;1;211;0.01;2;Germany;Western Europe;Biocom AG;2006-2013;"Biotechnology (Q4); Drug Discovery (Q4)"
607;5200152843;Farmaceutico Hospitales;journal;02144697;0.1;Q4;3;14;80;181;0;63;0;12.93;Spain;Western Europe;Ediciones Mayo S.A.;2006-2012;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
608;15680;Giornale di Neuropsicofarmacologia;journal;19711387, 03919048;0.1;Q4;1;0;45;0;0;38;0;0;Italy;Western Europe;CIC Edizioni Internazionali s.r.l.;1996-2008;"Neurology (clinical) (Q4); Neuropsychology and Physiological Psychology (Q4); Neuroscience (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
609;19700174971;Indian Journal of Forensic Medicine and Toxicology (discontinued);journal;09739122, 09739130;0.1;Q4;12;32;19;442;2;19;0.11;13.81;India;Asiatic Region;Institute of Medico-legal Publications;2008-2021;"Health, Toxicology and Mutagenesis (Q4); Law (Q4); Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
610;5000158120;Pharmacy News;journal;1448207X;0.1;Q4;1;98;723;2;0;248;0;0.02;United Kingdom;Western Europe;Reed Business Publishing;2006-2009;"Pharmaceutical Science (Q4); Pharmacology (nursing) (Q4)"
611;25197;Revista de Toxicologia (discontinued);journal;02127113;0.1;Q4;11;11;47;376;1;46;0;34.18;Spain;Western Europe;Asociacion Espanola de Toxicologia;1989-2017, 2020;Toxicology (Q4)
612;5800207507;Side Effects of Drugs Annual;book series;03786080;0.1;Q4;6;53;103;3707;2;53;0.02;69.94;Netherlands;Western Europe;Elsevier;1977-1995, 1997-2005, 2007-2012, 2014-2020;"Drug Guides (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
613;21100239606;Therapeutic Innovation and Regulatory Science;journal;21684790, 21684804;0.1;Q4;46;159;282;2209;185;273;0.57;13.89;United States;Northern America;SAGE Publications Inc.;1970, 1972, 1974-2006, 2008-2011, 2013-2021;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4); Public Health, Environmental and Occupational Health (Q4)"
614;17700156777;Advances in Pharmacological Sciences;journal;16876342, 16876334;;-;38;4;0;180;0;0;0;45;United States;Northern America;Hindawi Publishing Corporation;2009-2019;"Molecular Medicine; Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
615;19700171017;African Journal of Pharmacy and Pharmacology;journal;19960816;;-;33;102;0;2775;0;0;0;27.21;Nigeria;Africa;Academic Journals;2009-2011;"Pharmaceutical Science; Pharmacology"
616;21100304895;Archives of Clinical Infectious Diseases;journal;23452641;;-;17;45;0;976;0;0;0;21.69;Iran;Middle East;Shahid Beheshti University of Medical Sciences;2012-2021;"Cardiology and Cardiovascular Medicine; Critical Care and Intensive Care Medicine; Infectious Diseases; Public Health, Environmental and Occupational Health; Toxicology"
617;19700171709;Arhiv za Farmaciju;journal;00041963;;-;4;36;0;868;0;0;0;24.11;Serbia;Eastern Europe;Farmaceutsko Drustvo Srbije;1954-1955, 2009-2021;"Pharmaceutical Science; Pharmacology"
618;19700174904;Asian Journal of Pharmaceutical and Clinical Research (discontinued);journal;09742441, 24553891;;-;41;59;0;1360;0;0;0;23.05;India;Asiatic Region;Asian Journal of Pharmaceutical and Clinical Research;2009-2018, 2020-2021;"Pharmaceutical Science; Pharmacology; Pharmacology (medical)"
619;19700175119;Asian Journal of Pharmaceutical Sciences;journal;18180876, 2221285X;;-;48;40;0;1219;0;0;0;30.48;China;Asiatic Region;Shenyang Pharmaceutical University;2009-2021;"Pharmaceutical Science; Pharmacology"
620;19700174931;Asian Journal of Pharmaceutics (discontinued);journal;1998409X, 09738398;;-;23;61;0;1291;0;0;0;21.16;India;Asiatic Region;Wolters Kluwer Medknow Publications;2009-2018, 2020-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
621;19700175121;Azerbaijan Pharmaceutical and Pharmacotherapy Journal;journal;19941951;;-;3;36;0;414;0;0;0;11.5;Azerbaijan;Eastern Europe;Azerbaijan Medical University;2009-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
622;18200156711;Bangladesh Journal of Pharmacology;journal;1991007X, 19910088;;-;26;35;0;654;0;0;0;18.69;Bangladesh;Asiatic Region;Bangladesh Pharmacological Society;2009-2021;Pharmacology
623;19700188217;Bioanalysis;journal;17576180, 17576199;;-;62;128;0;6525;0;0;0;50.98;United Kingdom;Western Europe;Future Science;2009-2021;"Analytical Chemistry; Clinical Biochemistry; Medical Laboratory Technology; Medicine (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
624;19700174924;Biomedical and Pharmacology Journal;journal;09746242;;-;22;88;0;1498;0;0;0;17.02;India;Asiatic Region;Oriental Scientific Publishing Company;2009-2021;Pharmacology
625;19700174961;BioProcess International;trade journal;15426319;;-;23;150;0;803;0;0;0;5.35;United States;Northern America;PJB Publications Ltd.;2009-2017;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Drug Discovery"
626;19700200880;Botulinum Journal;journal;17547326, 17547318;;-;6;8;0;195;0;0;0;24.38;Switzerland;Western Europe;Inderscience Publishers;2009-2013, 2016;"Biochemistry; Cellular and Molecular Neuroscience; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
627;19200156925;Cancer Therapy;journal;15439143, 15439135;;-;8;47;0;2126;0;0;0;45.23;United States;Northern America;Gene Therapy Press;2009-2014;"Cancer Research; Oncology; Pharmacology"
628;19700173109;Contract Pharma;trade journal;15443469, 23806559;;-;4;103;0;80;0;0;0;0.78;United States;Northern America;Contract Pharma;2009-2018;"Industrial Relations; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
629;19700175244;Current Radiopharmaceuticals;journal;18744710, 18744729;;-;26;33;0;1338;0;0;0;40.55;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2009-2021;"Pharmacology; Radiology, Nuclear Medicine and Imaging"
630;21101055116;Current Reviews in Clinical and Experimental Pharmacology;journal;27724328, 27724336;;-;43;28;75;1790;232;75;2.94;63.93;United Arab Emirates;Middle East;Bentham Science Publishers;2021;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
631;19500157042;Currents in Pharmacy Teaching and Learning;journal;18771297;;-;23;18;0;357;0;0;0;19.83;United States;Northern America;Elsevier Inc.;2009-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous); Pharmacy"
632;17300154738;Current Trends in Biotechnology and Pharmacy;journal;22307303, 09738916;;-;14;50;0;1478;0;0;0;29.56;India;Asiatic Region;Association of Biotechnology and Pharmacy;2009-2021;"Biotechnology; Drug Discovery; Pharmaceutical Science"
633;19700174905;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;journal;11787007;;-;50;22;0;1209;0;0;0;54.95;New Zealand;Pacific Region;Dove Medical Press Ltd.;2009-2021;"Internal Medicine; Pharmacology"
634;17600155051;Drug Development and Delivery;trade journal;1944818X, 15372898;;-;11;81;0;741;0;0;0;9.15;United States;Northern America;Drug Delivery Technology;2009-2021;Pharmaceutical Science
635;19700175086;Drug, Healthcare and Patient Safety;journal;11791365;;-;25;10;0;367;0;0;0;36.7;New Zealand;Pacific Region;Dove Medical Press Limited;2009-2021;"Health Policy; Pharmacology"
636;19700174958;Drug Testing and Analysis;journal;19427611, 19427603;;-;57;81;0;2713;0;0;0;33.49;United Kingdom;Western Europe;John Wiley and Sons Ltd;2009-2021;"Analytical Chemistry; Environmental Chemistry; Pharmaceutical Science; Spectroscopy"
637;21100938253;Environmental Pollutants and Bioavailability;journal;26395940, 26395932;;-;33;28;54;930;47;54;0.8;33.21;United Kingdom;Western Europe;Taylor and Francis Ltd.;2019-2021;"Chemical Health and Safety; Health, Toxicology and Mutagenesis; Toxicology"
638;15600154705;EnvironmentAsia;journal;19061714;;-;19;16;0;292;0;0;0;18.25;Thailand;Asiatic Region;Thai Society of Higher Eduation Institutes on Environment;2009-2021;"Environmental Science (miscellaneous); Toxicology"
639;19700182785;Ethiopian Pharmaceutical Journal;journal;10295933;;-;5;15;0;361;0;0;0;24.07;Ethiopia;Africa;Ethiopian Pharmaceutical Journal;2009;"Pharmaceutical Science; Pharmacology"
640;19700174996;European Life Science Journal;trade journal;20001444;;-;1;86;0;0;0;0;0;0;Norway;Western Europe;International Business Media AB;2009-2011;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
641;21100804474;European Pharmaceutical Journal;journal;24536725;;-;8;21;0;351;0;0;0;16.71;Germany;Western Europe;de Gruyter;2016-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
642;19700174925;European Pharmaceutical Review;trade journal;13608606;;-;8;29;0;402;0;0;0;13.86;United Kingdom;Western Europe;Russell Publishing LLC;2009-2019;"Biochemistry; Biophysics; Biotechnology; Molecular Medicine; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
643;19700170617;EXCLI Journal;journal;16112156;;-;43;28;0;924;0;0;0;33;Germany;Western Europe;Leibniz Research Centre for Working Environment and Human Factors;2009-2021;"Animal Science and Zoology; Drug Discovery; Molecular Medicine; Pharmacology"
644;19500157008;Fooyin Journal of Health Sciences;journal;18778607, 18778615;;-;6;14;0;387;0;0;0;27.64;Netherlands;Western Europe;Elsevier BV;2009-2010;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Biomedical Engineering; Drug Discovery; Medicine (miscellaneous)"
645;19700174974;Future Medicinal Chemistry;journal;17568919, 17568927;;-;76;120;0;8645;0;0;0;72.04;United Kingdom;Western Europe;Future Science;2009-2021;"Drug Discovery; Molecular Medicine; Pharmacology"
646;19400158813;HIV Therapy;journal;17584329, 17584310;;-;12;60;0;3725;0;0;0;62.08;United Kingdom;Western Europe;Future Medicine Ltd.;2009-2010;"Dermatology; Drug Discovery; Infectious Diseases; Pharmacology; Pharmacology (medical); Virology"
647;19700175015;Infection and Drug Resistance;journal;11786973;;-;44;6;0;435;0;0;0;72.5;New Zealand;Pacific Region;Dove Medical Press Ltd.;2009-2021;"Infectious Diseases; Pharmacology; Pharmacology (medical)"
648;15500154707;International Journal of Biological Chemistry (discontinued);journal;21522561, 1819155X;;-;16;18;0;432;0;0;0;24;Pakistan;Asiatic Region;Asian Network for Scientific Information;2009-2016;"Biochemistry; Pharmacology"
649;19700182039;International Journal of Green Nanotechnology: Biomedicine;journal;1943085X, 19430906;;-;15;11;0;580;0;0;0;52.73;United States;Northern America;Taylor and Francis Ltd.;2009-2012;"Biomedical Engineering; Nanoscience and Nanotechnology; Pharmaceutical Science"
650;19700174900;International Journal of Green Pharmacy (discontinued);journal;19984103, 09738258;;-;26;68;0;1574;0;0;0;23.15;India;Asiatic Region;Wolters Kluwer Medknow Publications;2009-2018, 2020-2021;"Pharmaceutical Science; Pharmacology"
651;19700174926;International Journal of Health Research;journal;15969819, 15969886;;-;9;33;0;762;0;0;0;23.09;Nigeria;Africa;Poracom Academic Publishers;2009-2012;"Medicine (miscellaneous); Pharmacology"
652;19700174810;International Journal of Pharmacy and Pharmaceutical Sciences (discontinued);journal;09751491;;-;49;77;0;1625;0;0;0;21.1;India;Asiatic Region;IJPPS;2009-2017, 2020-2021;"Pharmaceutical Science; Pharmacology"
653;19700175060;International Journal of PharmTech Research (discontinued);journal;09744304;;-;48;275;0;5505;0;0;0;20.02;India;Asiatic Region;Sphinx Knowledge House;2009-2016;"Pharmaceutical Science; Pharmacology"
654;19700175125;Internet Journal of Pharmacology;journal;15312976;;-;8;41;0;1284;0;0;0;31.32;United States;Northern America;Internet Scientific Publications, LLC;2009-2011;Pharmacology
655;19700175049;Internet Journal of Toxicology;journal;15593916;;-;7;17;0;397;0;0;0;23.35;United States;Northern America;Internet Scientific Publications, LLC;2009-2011, 2013, 2015;Toxicology
656;19700174628;Iranian Journal of Basic Medical Sciences;journal;20083874, 20083866;;-;44;13;47;450;13;47;0.28;34.62;Iran;Middle East;Mashhad University of Medical Sciences;2007-2021;"Biochemistry; Biophysics; Clinical Biochemistry; Drug Discovery; Immunology and Microbiology (miscellaneous) "
657;19700175056;Jordan Journal of Pharmaceutical Sciences;journal;19957157;;-;10;16;0;348;0;0;0;21.75;Jordan;Middle East;The University of Jordan;2009-2021;Pharmaceutical Science
658;27767;Journal of Forensic Medicine and Toxicology;journal;09711929;;-;18;25;67;412;2;66;0.04;16.48;India;Asiatic Region;;1997-2020;"Pathology and Forensic Medicine; Toxicology"
659;19600156803;Journal of Medicinal Plant Research;journal;19960875;;-;63;193;0;5648;0;0;0;29.26;Nigeria;Africa;Academic Journals;2009-2012;"Complementary and Alternative Medicine; Drug Discovery; Pharmaceutical Science; Pharmacology; Plant Science"
660;19700174933;Journal of Pharmaceutical Sciences and Research (discontinued);journal;09751459;;-;30;66;0;1293;0;0;0;19.59;India;Asiatic Region;;2009-2018, 2020-2021;Pharmaceutical Science
661;19700175098;Klinicka Farmakologie a Farmacie;journal;12127973, 18035353;;-;5;38;0;683;0;0;0;17.97;Czech Republic;Eastern Europe;SOLEN S.R.O.;2009-2021;"Pharmaceutical Science; Pharmacology; Pharmacy"
662;21100874234;Latin American Journal of Pharmacy;journal;23623853, 03262383;;-;26;146;388;3916;124;388;0.33;26.82;Argentina;Latin America;Colegio de Farmaceuticos de la Provincia de Buenos Aires;2007-2021;"Drug Discovery; Pharmaceutical Science"
663;19700169211;Life Science Clusters;trade journal;17528119;;-;0;60;0;23;0;0;0;0.38;United Kingdom;Western Europe;Avakado Ltd;2009-2010;"Biotechnology; Industrial Relations; Management of Technology and Innovation; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
664;19700174906;Molecular and Cellular Pharmacology;journal;19381247;;-;26;34;0;1803;0;0;0;53.03;United States;Northern America;Lumitext Publishing;2009-2017, 2020-2021;"Molecular Biology; Pharmaceutical Science"
665;17700156303;Neuromethods;book series;19406045, 08932336;;-;21;64;0;4981;0;0;0;77.83;United States;Northern America;Humana Press;2009-2022;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Neuroscience (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous); Psychiatry and Mental Health"
666;21100862294;Neuropsychopharmacology Reports;journal;2574173X;;-;14;1;1;36;0;1;0;36;United States;Northern America;"John Wiley &amp; Sons Inc.";2018-2021;"Clinical Psychology; Pharmacology; Pharmacology (medical); Psychiatry and Mental Health"
667;19700175602;Next Generation Pharmaceutical;trade journal;-;;-;1;109;0;4;0;0;0;0.04;United Kingdom;Western Europe;GDS International;2009-2011;"Drug Discovery; Marketing; Organizational Behavior and Human Resource Management; Pharmaceutical Science; Pharmacology; Strategy and Management"
668;19700174997;ONdrugDelivery;trade journal;2049145X, 20491468;;-;6;4;0;0;0;0;0;0;United Kingdom;Western Europe;Frederick Furness Publishing;2009-2020;Pharmaceutical Science
669;19700175785;Open Access Journal of Clinical Trials;journal;11791519;;-;12;4;0;332;0;0;0;83;New Zealand;Pacific Region;Dove Medical Press Ltd.;2009-2021;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
670;19700175004;Open Medicinal Chemistry Journal;journal;18741045;;-;18;1;0;23;0;0;0;23;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2009-2020;"Drug Discovery; Molecular Medicine; Pharmaceutical Science; Pharmacology"
671;19700175124;Open Neuropsychopharmacology Journal;journal;18765238;;-;5;12;0;838;0;0;0;69.83;Netherlands;Western Europe;Bentham Science Publishers B.V.;2009-2012;"Pharmacology; Pharmacology (medical); Psychiatry and Mental Health"
672;19700175061;Open Pharmacology Journal;journal;18741436;;-;6;5;0;231;0;0;0;46.2;Netherlands;Western Europe;Bentham Science Publishers B.V.;2009-2013;"Drug Discovery; Molecular Medicine; Pharmaceutical Science; Pharmacology"
673;19700175039;Open Toxicology Journal;journal;18743404;;-;8;7;0;264;0;0;0;37.71;Netherlands;Western Europe;Bentham Science Publishers B.V.;2009-2010, 2012-2013;Toxicology
674;19700175040;Open Vaccine Journal;journal;18750354;;-;9;13;0;772;0;0;0;59.38;Netherlands;Western Europe;Bentham Science Publishers B.V.;2009-2013;"Drug Discovery; Immunology; Pharmaceutical Science"
675;19700181430;Pharmaceutical Manufacturing and Packing Sourcer;trade journal;14631245;;-;3;71;0;238;0;0;0;3.35;United Kingdom;Western Europe;Samedan Ltd;2009-2016, 2018-2019;"Pharmaceutical Science; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
676;19700175034;Pharmaceutical Processing;trade journal;10499156;;-;3;58;0;73;0;0;0;1.26;United States;Northern America;Advantage Business Media;2009-2018;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
677;19700175002;Pharmaceutical Reviews;journal;19185561;;-;5;32;0;1341;0;0;0;41.91;Canada;Northern America;;2009-2011;"Analytical Chemistry; Drug Discovery; Pharmaceutical Science; Pharmacology"
678;17700156714;Pharmaceuticals;journal;14248247;;-;69;23;0;1175;0;0;0;51.09;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2009-2021;"Molecular Medicine; Pharmaceutical Science"
679;19700189400;Pharmaceutical Sciences;journal;23832886, 1735403X;;-;19;42;0;1115;0;0;0;26.55;Iran;Middle East;Tabriz University of Medical Sciences;2009-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
680;19700188360;Pharmaceutics;journal;19994923;;-;68;2;0;29;0;0;0;14.5;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2010-2021;Pharmaceutical Science
681;19700175029;Pharmacogenomics and Personalized Medicine;journal;11787066;;-;31;9;0;508;0;0;0;56.44;New Zealand;Pacific Region;Dove Medical Press Ltd.;2009-2021;"Molecular Medicine; Pharmacology"
682;19700175096;Pharmacognosy Journal;journal;09753575;;-;25;40;0;647;0;0;0;16.18;India;Asiatic Region;EManuscript Technologies;2009-2021;"Drug Discovery; Pharmacology"
683;19700175143;Pharmacognosy Reviews (discontinued);journal;09737847, 09762787;;-;54;41;0;3074;0;0;0;74.98;India;Asiatic Region;Wolters Kluwer Medknow Publications;2009-2018;"Complementary and Alternative Medicine; Drug Discovery; Pharmacology; Plant Science"
684;20543;Pharmacometrics;journal;03008533;;-;6;16;0;163;0;0;0;10.19;Japan;Asiatic Region;Japanese Society of Pharmacometrics;1973-2004, 2009-2012;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
685;19700181241;Physiology and Pharmacology;journal;17350581;;-;12;46;0;1432;0;0;0;31.13;Iran;Middle East;Neuroscience Research Center;2009-2021;"Pharmacology; Physiology"
686;19500156813;Procedia in Vaccinology;journal;1877282X;;-;15;32;0;591;0;0;0;18.47;Netherlands;Western Europe;Elsevier;2009-2012;"Drug Discovery; Immunology; Infectious Diseases; Pharmaceutical Science"
687;19700175018;Psychopharmacology and Biological Narcology;journal;16068181, 20705670;;-;3;11;0;342;0;0;0;31.09;Russian Federation;Eastern Europe;JSC;2009-2012;"Pharmacology; Psychiatry and Mental Health"
688;19700177006;Psychopharm Review;trade journal;19369255;;-;4;12;0;551;0;0;0;45.92;United States;Northern America;Lippincott Williams and Wilkins Ltd.;2009-2014;"Pharmacology; Pharmacology (medical); Psychiatry and Mental Health"
689;21101055117;Recent Advances in Anti-Infective Drug Discovery;journal;27724352, 27724344;;-;33;21;74;1744;152;74;2.09;83.05;United Arab Emirates;Middle East;Bentham Science Publishers;2021;"Drug Discovery; Infectious Diseases; Pharmacology (medical)"
690;17500155003;Records of Natural Products;journal;13076167;;-;33;23;0;499;0;0;0;21.7;Turkey;Middle East;ACG Publications;2009-2022;"Drug Discovery; Organic Chemistry; Pharmacology; Plant Science"
691;19600157763;Research in Pharmaceutical Sciences;journal;17355362, 17359414;;-;33;12;0;262;0;0;0;21.83;India;Asiatic Region;Wolters Kluwer Medknow Publications;2009-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
692;17700155411;Research Journal of Environmental Toxicology (discontinued);journal;18193420;;-;18;20;0;671;0;0;0;33.55;United States;Northern America;Academic Journals Inc.;2009-2016;"Health, Toxicology and Mutagenesis; Pollution; Toxicology"
693;19700174987;Research Journal of Toxins (discontinued);journal;18193560, 21517258;;-;3;2;0;86;0;0;0;43;United States;Northern America;Academic Journals Inc.;2009, 2014, 2016;"Agronomy and Crop Science; Food Science; Toxicology"
694;19700174940;SA Pharmaceutical Journal;journal;10151362;;-;7;137;0;804;0;0;0;5.87;South Africa;Africa;Medpharm Publications;2009-2021;Pharmaceutical Science
695;16800154712;Sp2;trade journal;1476184X;;-;2;64;0;50;0;0;0;0.78;United Kingdom;Western Europe;Avakado Ltd;2009-2014;"Drug Discovery; Molecular Medicine"
696;19700175006;Thai Journal of Pharmaceutical Sciences;journal;01254685, 19054637;;-;12;12;0;434;0;0;0;36.17;Thailand;Asiatic Region;Thai Journal of Pharmaceutical Sciences;2009-2021;"Pharmaceutical Science; Pharmacology"
697;19700175099;Topics in Medicinal Chemistry;book series;1862247X, 18622461;;-;12;10;0;913;0;0;0;91.3;Germany;Western Europe;Springer Verlag;2009-2012, 2014-2021;"Drug Discovery; Molecular Medicine"
698;21100226424;Toxicology and Environmental Health Sciences;journal;20059752, 22337784;;-;17;30;0;833;0;0;0;27.77;South Korea;Asiatic Region;Korean Society of Environmental Risk Assessment and Health Science;2009-2021;"Health, Toxicology and Mutagenesis; Toxicology"
699;19700188352;Toxins;journal;20726651;;-;91;16;0;0;0;0;0;0;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2009-2021;"Health, Toxicology and Mutagenesis; Toxicology"
700;18800156708;Tropical Journal of Pharmaceutical Research;journal;15965996, 15969827;;-;39;72;0;1549;0;0;0;21.51;Nigeria;Africa;Pharmacotherapy Group;2009-2021;"Pharmaceutical Science; Pharmacology (medical)"
701;19700170837;Vitae;journal;21452660, 01214004;;-;15;40;0;1255;0;0;0;31.38;Colombia;Latin America;Universidad de Antioquia;2009-2021;"Applied Microbiology and Biotechnology; Bioengineering; Biotechnology; Food Science; Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
702;18200156702;World Mycotoxin Journal;journal;18750710, 18750796;;-;40;49;0;2215;0;0;0;45.2;Netherlands;Western Europe;Wageningen Academic Publishers;2009-2021;"Food Science; Public Health, Environmental and Occupational Health; Toxicology"
